STOCK TITAN

SIM Acquisition Corp. I issues going-concern warning

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
10-Q

Rhea-AI Filing Summary

SIM Acquisition Corp. I (SIMA) reported a $413,568 net loss for the third quarter of 2026, compared with $2,252,165 net income in the third quarter of 2025. For the first nine months, net income was $1,997,005, versus $6,772,463 a year earlier. Trust-account interest for the nine months was $3,225,584, compared with $7,453,481, primarily reflecting the reduced trust balance after redemptions.

At September 30, 2026, cash was $280,224, the working capital deficit was $1,262,744, and trust assets were $6,168,416. Management said insufficient liquidity and the requirement to complete a business combination by July 12, 2027 or liquidate raise substantial doubt about the company’s ability to continue as a going concern; its proposed plans were not considered probable of alleviating that doubt.

Under an October 2, 2026 binding letter of intent, AIT would merge with a SIMA subsidiary and SIMA would issue approximately 50,000,000 shares to AIT equity holders. The proposed transaction remains subject to due diligence, definitive documents, and board and shareholder approvals. The parties had not executed a definitive merger agreement.

0 points · 0 major

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

1 major · 3 points

How the balance works

Positive

  • None.

Negative

  • Major pointManagement cites substantial doubt, insufficient liquidity and a July 12, 2027 liquidation deadline.
  • Moderate pointThird-quarter results shifted to a $413,568 net loss from $2,252,165 net income.
  • Minor pointNine-month net income was $1,997,005, versus $6,772,463 a year earlier.
Third-quarter 2026 net loss $413,568 Three months ended September 30, 2026
Third-quarter 2025 net income $2,252,165 Three months ended September 30, 2025
Nine-month 2026 net income $1,997,005 Nine months ended September 30, 2026
Nine-month 2025 net income $6,772,463 Nine months ended September 30, 2025
Trust Account assets $6,168,416 As of September 30, 2026
Cash $280,224 As of September 30, 2026
Working capital deficit $1,262,744 As of September 30, 2026
Shares proposed for issuance to AIT equity holders Approximately 50,000,000 shares At closing under the binding letter of intent
substantial doubt financial
"raises substantial doubt about the Company’s ability to continue as a going concern"
working capital deficit financial
"the Company had a working capital deficit of $1,262,744"
A working capital deficit occurs when a company's short-term obligations—like bills, supplier payments and near-term debt—are larger than its readily available short-term resources such as cash, money expected from customers, and inventory that can be sold. Like a household whose monthly bills exceed its checking account, it signals potential difficulty paying immediate expenses, which matters to investors because it raises the chance the company will need outside financing or cut operations, affecting risk and value.
Trust Account financial
"cash and marketable securities held in Trust Account"
A trust account is a special bank or brokerage account where assets are held and managed by a designated person or firm (the trustee) for the benefit of another person or group (the beneficiary). It matters to investors because it separates assets from personal or corporate funds, can protect assets, control how and when money is used, and may affect tax or legal rights—think of it as a locked drawer opened only under agreed rules.
paid-in-kind interest financial
"Interest is paid in kind quarterly by adding it to the principal balance"
Paid-in-kind interest is interest on a loan or bond that is paid by issuing more debt or additional securities instead of cash, so the borrower adds the unpaid interest to the principal balance. For investors, it matters because it preserves the borrower’s cash now but increases the total debt or dilutes ownership later—like taking a ballooning credit card balance instead of paying the bill—and can raise risk of higher leverage and reduced cash returns.
original issue discount financial
"amortization of original issue discount"
Original issue discount (OID) is the difference between a debt security’s face value and the lower price at which it is first sold, treated as additional interest that accrues over the life of the instrument. For investors it matters because OID raises the effective yield and changes taxable income and the holding’s cost basis over time — think of buying a $100 voucher for $90 and recognizing the $10 gain as earned interest as the voucher approaches maturity.
fully diluted capitalization financial
"awards of up to 10.0% of its fully diluted capitalization"
Total number of company shares that would exist if every outstanding instrument that can be converted into common stock—such as stock options, warrants, convertible debt and restricted stock units—were exercised or converted. Investors use this “all-in” share count to see ownership percentages and to calculate per-share figures (like earnings per share) after potential dilution; think of a cake sliced now plus every extra slice that could be cut if all promises were fulfilled.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What would AIT shareholders receive in SIMA’s proposed transaction?

AIT equity holders would receive approximately 50,000,000 shares of common stock at closing. The combined company would adopt an equity incentive plan for awards of up to 10.0% of its fully diluted capitalization. John Chiorando, AIT’s current Chief Executive Officer, would serve as Chief Executive Officer and Chairman, and certain significant AIT stockholders would be subject to a 12-month lock-up. Completion is subject to due diligence, definitive documents, and board and shareholder approvals.

When could AIT owe SIMA a $5 million termination fee?

AIT is required to pay SIMA a $5,000,000 termination fee in specified circumstances, including failing to deliver certain audited and reviewed financial statements by November 15, 2026, or failing to execute definitive documents by December 31, 2026. The exclusivity period was extended through December 31, 2026. Under the fee reduction agreement, 50% of any termination fee received would be applied toward the reduced deferred fee.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
http://fasb.org/srt/2026#ChiefFinancialOfficerMember P10D false Q3 0002014982 --12-31 0002014982 2026-07-01 2026-09-30 0002014982 us-gaap:SubsequentEventMember sima:WCLPromissoryNoteMember 2026-11-13 0002014982 sima:WCLPromissoryNoteMember sima:SponsorMember 2026-08-27 2026-08-27 0002014982 us-gaap:SubsequentEventMember sima:WCLPromissoryNoteMember sima:SponsorMember 2026-11-13 0002014982 us-gaap:SubsequentEventMember 2026-10-02 2026-10-02 0002014982 us-gaap:SubsequentEventMember us-gaap:CommonStockMember 2026-10-02 2026-10-02 0002014982 2026-01-01 2026-09-30 0002014982 2025-01-01 2025-09-30 0002014982 2025-07-01 2025-09-30 0002014982 sima:FounderShares1Member us-gaap:MeasurementInputDiscountRateMember 2024-04-18 0002014982 sima:FounderShares1Member us-gaap:MeasurementInputCommodityMarketPriceMember 2024-04-18 0002014982 sima:FounderShares1Member us-gaap:MeasurementInputDiscountForLackOfMarketabilityMember 2024-04-18 0002014982 us-gaap:MeasurementInputCommodityMarketPriceMember sima:PublicWarrantsMember 2024-07-11 0002014982 us-gaap:MeasurementInputPriceVolatilityMember sima:PublicWarrantsMember 2024-07-11 0002014982 us-gaap:MeasurementInputOptionVolatilityMember sima:PublicWarrantsMember 2024-07-11 0002014982 us-gaap:MeasurementInputRiskFreeInterestRateMember sima:PublicWarrantsMember 2024-07-11 0002014982 us-gaap:MeasurementInputExpectedTermMember sima:PublicWarrantsMember 2024-07-11 0002014982 us-gaap:MeasurementInputSharePriceMember sima:PublicWarrantsMember 2024-07-11 0002014982 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2025-12-31 0002014982 us-gaap:FairValueMeasurementsRecurringMember 2025-12-31 0002014982 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2026-09-30 0002014982 us-gaap:FairValueMeasurementsRecurringMember 2026-09-30 0002014982 sima:LegalFeeArrangementMember 2026-09-30 0002014982 sima:LegalFeeArrangementMember 2026-01-01 2026-09-30 0002014982 sima:LegalFeeArrangementMember 2026-09-02 0002014982 sima:LegalFeeArrangementMember 2026-09-02 2026-09-02 0002014982 sima:LegalFeeArrangementMember 2026-09-03 2026-09-03 0002014982 sima:FeeReductionAgreementMember 2026-09-30 0002014982 sima:UnderwritingAgreementMember 2026-01-01 2026-09-30 0002014982 sima:UnderwritingAgreementMember 2026-09-30 0002014982 us-gaap:OverAllotmentOptionMember sima:UnderwritingAgreementMember 2024-07-11 2024-07-11 0002014982 sima:UnderwritingAgreementMember 2024-07-11 0002014982 us-gaap:OverAllotmentOptionMember sima:UnderwritingAgreementMember 2026-01-01 2026-09-30 0002014982 us-gaap:CommonStockMember 2026-09-30 0002014982 sima:PublicWarrantsMember 2026-01-01 2026-09-30 0002014982 sima:PrivatePlacementWarrantsMember 2025-12-31 0002014982 sima:PrivatePlacementWarrantsMember 2026-09-30 0002014982 sima:PublicWarrantsMember 2025-12-31 0002014982 sima:PublicWarrantsMember 2026-09-30 0002014982 us-gaap:CommonClassBMember 2026-09-30 0002014982 us-gaap:CommonClassAMember 2026-09-30 0002014982 us-gaap:CommonClassAMember 2026-01-01 2026-09-30 0002014982 us-gaap:CommonClassAMember 2026-05-11 2026-05-11 0002014982 us-gaap:CommonClassBMember 2026-05-11 2026-05-11 0002014982 us-gaap:CommonClassBMember 2025-12-31 0002014982 us-gaap:CommonClassBMember 2026-01-01 2026-09-30 0002014982 us-gaap:CommonClassAMember 2025-12-31 0002014982 2026-09-30 0002014982 2026-09-30 2026-09-30 0002014982 sima:DominariMember 2026-09-30 2026-09-30 0002014982 us-gaap:AdministrativeServiceMember 2026-09-30 0002014982 2026-05-01 2026-05-31 0002014982 sima:MrKutcherMember 2026-05-01 2026-05-31 0002014982 us-gaap:AdministrativeServiceMember sima:MrHayesMember 2026-03-18 2026-03-18 0002014982 sima:SponsorMember us-gaap:AdministrativeServiceMember 2026-01-01 2026-09-30 0002014982 sima:WCLPromissoryNoteMember 2026-01-01 2026-09-30 0002014982 sima:WCLPromissoryNoteMember 2026-07-01 2026-09-30 0002014982 sima:WCLPromissoryNoteMember 2026-09-30 0002014982 sima:WCLPromissoryNoteMember 2026-09-30 2026-09-30 0002014982 sima:WCLPromissoryNoteMember 2026-08-27 0002014982 sima:SecondDrawMember sima:WCLPromissoryNoteMember 2026-08-27 2026-08-27 0002014982 sima:FirstDrawMember sima:WCLPromissoryNoteMember 2026-08-27 2026-08-27 0002014982 sima:SponsorMember 2026-08-27 2026-08-27 0002014982 sima:WCLPromissoryNoteMember 2026-08-27 2026-08-27 0002014982 sima:WCLPromissoryNoteMember 2026-03-25 0002014982 sima:SecondDrawMember sima:WCLPromissoryNoteMember 2026-03-25 2026-03-25 0002014982 sima:WCLPromissoryNoteMember 2026-03-25 2026-03-25 0002014982 sima:FirstDrawMember sima:WCLPromissoryNoteMember 2026-03-25 0002014982 sima:WCLPromissoryNoteMember 2026-03-18 2026-03-18 0002014982 sima:WCLPromissoryNoteMember 2026-03-18 0002014982 us-gaap:OtherAffiliatesMember 2025-12-31 0002014982 sima:WorkingCapitalLoansMember 2026-09-30 0002014982 sima:PrivatePlacementWarrantMember sima:WorkingCapitalLoansMember 2026-09-30 0002014982 sima:WorkingCapitalLoansMember 2026-01-01 2026-09-30 0002014982 us-gaap:IPOMember sima:PromissoryNoteMember 2024-03-08 0002014982 us-gaap:CommonClassAMember sima:PrivatePlacementWarrantMember sima:CantorMember 2026-09-30 0002014982 sima:PrivatePlacementWarrantMember sima:CantorMember 2026-01-01 2026-09-30 0002014982 sima:PrivatePlacementWarrantMember sima:CantorMember 2026-09-30 0002014982 sima:FounderShares1Member srt:BoardOfDirectorsChairmanMember 2026-01-01 2026-09-30 0002014982 sima:FounderShares1Member 2026-01-01 2026-09-30 0002014982 sima:FounderShares1Member 2024-04-01 2024-04-30 0002014982 sima:FounderShares1Member sima:ThreeFormerDirectorsMember 2024-04-01 2024-04-30 0002014982 sima:IndependentDirectorsMember 2024-04-30 0002014982 sima:IndependentDirectorsMember 2024-04-01 2024-04-30 0002014982 sima:FounderShares1Member sima:ThreeFormerDirectorsMember 2026-01-28 2026-01-28 0002014982 sima:FounderShares1Member 2026-01-28 2026-01-28 0002014982 sima:FounderShares1Member sima:SponsorMember 2026-01-28 2026-01-28 0002014982 sima:SponsorMember 2025-09-04 2025-09-04 0002014982 sima:FounderShares1Member 2024-05-01 2024-05-31 0002014982 sima:FounderShares1Member srt:BoardOfDirectorsChairmanMember 2024-05-01 2024-05-31 0002014982 sima:FounderShares1Member 2024-04-30 0002014982 sima:InitialShareholdersMember 2024-05-01 2024-05-31 0002014982 sima:FounderShares1Member us-gaap:CommonClassBMember 2024-01-29 0002014982 us-gaap:CommonClassBMember sima:SponsorMember 2024-01-29 2024-01-29 0002014982 sima:FounderShares1Member sima:SponsorMember 2024-01-29 0002014982 sima:FounderShares1Member sima:SponsorMember 2024-01-29 2024-01-29 0002014982 2024-07-11 0002014982 sima:CantorFitzgeraldCoMember sima:PrivatePlacementWarrantMember us-gaap:PrivatePlacementMember 2026-09-30 0002014982 sima:SponsorMember sima:PrivatePlacementWarrantMember 2024-07-11 0002014982 us-gaap:CommonClassAMember sima:PrivatePlacementWarrantMember 2024-07-11 0002014982 us-gaap:CommonClassAMember 2024-07-11 0002014982 sima:CantorFitzgeraldCoMember sima:PrivatePlacementWarrantMember 2024-07-11 0002014982 sima:SponsorMember sima:PrivatePlacementWarrantMember us-gaap:PrivatePlacementMember 2024-07-11 0002014982 sima:PrivatePlacementWarrantMember 2024-07-11 0002014982 sima:PrivatePlacementWarrantMember 2024-07-11 2024-07-11 0002014982 sima:PrivatePlacementWarrantMember us-gaap:IPOMember 2024-07-11 0002014982 us-gaap:IPOMember us-gaap:CommonStockMember 2026-01-01 2026-09-30 0002014982 us-gaap:IPOMember 2024-07-11 0002014982 us-gaap:OverAllotmentOptionMember 2024-07-11 2024-07-11 0002014982 us-gaap:IPOMember 2024-07-11 2024-07-11 0002014982 sima:ClassAOrdinarySharesSubjectToRedemptionMember 2026-09-30 0002014982 sima:ClassAOrdinarySharesSubjectToRedemptionMember 2026-07-01 2026-09-30 0002014982 sima:ClassAOrdinarySharesSubjectToRedemptionMember 2026-06-30 0002014982 sima:ClassAOrdinarySharesSubjectToRedemptionMember 2026-04-01 2026-06-30 0002014982 sima:ClassAOrdinarySharesSubjectToRedemptionMember 2026-03-31 0002014982 sima:ClassAOrdinarySharesSubjectToRedemptionMember 2026-01-01 2026-03-31 0002014982 sima:ClassAOrdinarySharesSubjectToRedemptionMember 2025-12-31 0002014982 sima:ClassAOrdinarySharesSubjectToRedemptionMember 2025-01-01 2025-12-31 0002014982 sima:ClassAOrdinarySharesSubjectToRedemptionMember 2024-12-31 0002014982 sima:ClassAOrdinarySharesSubjectToPossibleRedemptionMember 2026-01-01 2026-09-30 0002014982 sima:NonRedeemableClassAAndClassBOrdinarySharesMember 2025-01-01 2025-09-30 0002014982 sima:RedeemableClassAOrdinarySharesMember 2025-01-01 2025-09-30 0002014982 sima:NonRedeemableClassAAndClassBOrdinarySharesMember 2026-01-01 2026-09-30 0002014982 sima:RedeemableClassAOrdinarySharesMember 2026-01-01 2026-09-30 0002014982 sima:NonRedeemableClassAAndClassBOrdinarySharesMember 2025-07-01 2025-09-30 0002014982 sima:RedeemableClassAOrdinarySharesMember 2025-07-01 2025-09-30 0002014982 sima:NonRedeemableClassAAndClassBOrdinarySharesMember 2026-07-01 2026-09-30 0002014982 sima:RedeemableClassAOrdinarySharesMember 2026-07-01 2026-09-30 0002014982 sima:OrdinaryShareMember 2026-09-30 0002014982 2025-12-31 0002014982 sima:WCLPromissoryNoteMember srt:RestatementAdjustmentMember 2026-01-01 2026-09-30 0002014982 us-gaap:CommonStockMember 2026-09-30 0002014982 sima:PublicSharesMember 2026-09-30 0002014982 us-gaap:IPOMember 2026-01-01 2026-09-30 0002014982 sima:ExtensionOfTheCombinationPeriodAnd2026RedemptionsMember 2026-09-30 0002014982 sima:ExtensionOfTheCombinationPeriodAnd2026RedemptionsMember 2026-01-01 2026-09-30 0002014982 2026-04-26 0002014982 sima:SponsorMember sima:PrivatePlacementWarrantMember 2026-01-28 0002014982 us-gaap:IPOMember 2026-09-30 0002014982 sima:SponsorMember sima:PrivatePlacementWarrantMember 2026-09-30 0002014982 us-gaap:IPOMember us-gaap:CommonClassAMember sima:SponsorMember 2024-07-11 0002014982 us-gaap:OverAllotmentOptionMember 2024-07-11 0002014982 2025-09-30 0002014982 2024-12-31 0002014982 us-gaap:RetainedEarningsMember 2025-09-30 0002014982 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2025-09-30 0002014982 us-gaap:RetainedEarningsMember 2025-07-01 2025-09-30 0002014982 2025-06-30 0002014982 us-gaap:RetainedEarningsMember 2025-06-30 0002014982 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2025-06-30 0002014982 2025-04-01 2025-06-30 0002014982 us-gaap:RetainedEarningsMember 2025-04-01 2025-06-30 0002014982 2025-03-31 0002014982 us-gaap:RetainedEarningsMember 2025-03-31 0002014982 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2025-03-31 0002014982 2025-01-01 2025-03-31 0002014982 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0002014982 us-gaap:RetainedEarningsMember 2024-12-31 0002014982 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2024-12-31 0002014982 us-gaap:RetainedEarningsMember 2026-09-30 0002014982 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2026-09-30 0002014982 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2026-09-30 0002014982 us-gaap:RetainedEarningsMember 2026-07-01 2026-09-30 0002014982 2026-06-30 0002014982 us-gaap:RetainedEarningsMember 2026-06-30 0002014982 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2026-06-30 0002014982 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2026-06-30 0002014982 2026-04-01 2026-06-30 0002014982 us-gaap:RetainedEarningsMember 2026-04-01 2026-06-30 0002014982 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2026-04-01 2026-06-30 0002014982 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2026-04-01 2026-06-30 0002014982 2026-03-31 0002014982 us-gaap:RetainedEarningsMember 2026-03-31 0002014982 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2026-03-31 0002014982 2026-01-01 2026-03-31 0002014982 us-gaap:RetainedEarningsMember 2026-01-01 2026-03-31 0002014982 us-gaap:RetainedEarningsMember 2025-12-31 0002014982 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2025-12-31 0002014982 sima:ClassAAndBNonredeemableOrdinarySharesMember 2025-01-01 2025-09-30 0002014982 sima:ClassAAndBNonredeemableOrdinarySharesMember 2026-01-01 2026-09-30 0002014982 sima:ClassAAndBNonredeemableOrdinarySharesMember 2025-07-01 2025-09-30 0002014982 sima:ClassAAndBNonredeemableOrdinarySharesMember 2026-07-01 2026-09-30 0002014982 sima:ClassAOrdinarySharesSubjectToPossibleRedemptionMember 2025-01-01 2025-09-30 0002014982 sima:ClassAOrdinarySharesSubjectToPossibleRedemptionMember 2025-07-01 2025-09-30 0002014982 sima:ClassAOrdinarySharesSubjectToPossibleRedemptionMember 2026-07-01 2026-09-30 0002014982 sima:SponsorMember 2026-09-30 0002014982 us-gaap:CommonClassBMember 2026-11-13 0002014982 us-gaap:CommonClassAMember 2026-11-13 0002014982 sima:RedeemableWarrantsEachWholeWarrantExercisableForOneClassAOrdinaryShareAtAnExercisePriceOf1150PerShareMember 2026-01-01 2026-09-30 0002014982 sima:ClassAOrdinarySharesParValue00001PerShareMember 2026-01-01 2026-09-30 0002014982 sima:UnitsEachConsistingOfOneClassAOrdinaryShareAndOnehalfOfOneRedeemableWarrantMember 2026-01-01 2026-09-30 0002014982 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2025-12-31 0002014982 us-gaap:AdditionalPaidInCapitalMember 2025-12-31 0002014982 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2024-12-31 0002014982 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0002014982 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2026-03-31 0002014982 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2025-03-31 0002014982 us-gaap:AdditionalPaidInCapitalMember 2026-03-31 0002014982 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0002014982 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2026-01-01 2026-03-31 0002014982 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2026-01-01 2026-03-31 0002014982 us-gaap:AdditionalPaidInCapitalMember 2026-01-01 2026-03-31 0002014982 us-gaap:AdditionalPaidInCapitalMember 2026-04-01 2026-06-30 0002014982 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2026-09-30 0002014982 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2026-09-30 0002014982 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2025-12-31 0002014982 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2025-12-31 0002014982 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2026-07-01 2026-09-30 0002014982 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2026-07-01 2026-09-30 0002014982 us-gaap:AdditionalPaidInCapitalMember 2026-07-01 2026-09-30 0002014982 us-gaap:AdditionalPaidInCapitalMember 2026-09-30 0002014982 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2025-04-01 2025-06-30 0002014982 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2025-04-01 2025-06-30 0002014982 us-gaap:AdditionalPaidInCapitalMember 2025-04-01 2025-06-30 0002014982 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2025-07-01 2025-09-30 0002014982 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2025-07-01 2025-09-30 0002014982 us-gaap:AdditionalPaidInCapitalMember 2025-07-01 2025-09-30 0002014982 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2025-09-30 0002014982 us-gaap:AdditionalPaidInCapitalMember 2025-09-30 0002014982 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2025-01-01 2025-03-31 0002014982 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2025-01-01 2025-03-31 0002014982 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0002014982 us-gaap:AdditionalPaidInCapitalMember 2026-06-30 0002014982 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2025-06-30 0002014982 us-gaap:AdditionalPaidInCapitalMember 2025-06-30 0002014982 sima:SponsorMember 2025-12-31 iso4217:USD xbrli:pure xbrli:shares sima:segment iso4217:USD xbrli:shares
 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

(Mark One)
☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the quarterly period ended September 30, 2026
 
or
 
☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the transition period from              to              

 

Commission File Number: 001-42164

SIM Acquisition Corp. I

(Exact name of registrant as specified in its charter)

 

Cayman Islands   35-2838851
(State or other jurisdiction of
incorporation or organization)
  (I.R.S. Employer
Identification No.)

 

725 Fifth Avenue, 22nd Floor

New York, New York

  10022
(Address of principal executive offices)   (Zip Code)

 

(833) 746 2001

(Registrant’s telephone number, including area code)

 

Not Applicable

(Former name, former address and former fiscal year, if changed since last report)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Units, each consisting of one Class A Ordinary Share and one-half of one Redeemable Warrant   SIMAU   The Nasdaq Stock Market LLC
         
Class A Ordinary Shares, par value $0.0001 per share   SIMA   The Nasdaq Stock Market LLC
         
Redeemable Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share   SIMAW   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒  No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒   No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

  Large accelerated filer ☐ Accelerated filer ☐
  Non-accelerated filer ☒ Smaller reporting company ☒
    Emerging growth company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☒   No ☐

 

As of November 13, 2026, there were 3,552,768 Class A Ordinary Shares, par value $0.0001 per share, and 4,666,667 Class B Ordinary Shares, par value $0.0001 per share, of the registrant issued and outstanding.

 

 

 

 

 

 

SIM ACQUISITION CORP. I

 

FORM 10-Q FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2026

 

TABLE OF CONTENTS

 

      Page
PART I – FINANCIAL INFORMATION   1
       
Item 1. Financial Statements.   1
       
  Condensed Balance Sheets as of September 30, 2026 (Unaudited) and December 31, 2025.   1
       
  Unaudited Condensed Statements of Operations for the Three and Nine Months Ended September 30, 2026 and 2025.   2
       
  Unaudited Condensed Statements of Changes in Shareholders’ Deficit for the Three and Nine Months Ended September 30, 2026 and 2025.   3
       
  Unaudited Condensed Statements of Cash Flows for the Nine Months Ended September 30, 2026 and 2025.   4
       
  Notes to Unaudited Condensed Financial Statements.   5
       
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.   21
       
Item 3. Quantitative and Qualitative Disclosures About Market Risk.   27
       
Item 4. Controls and Procedures.   27
       
PART II – OTHER INFORMATION   28
       
Item 1. Legal Proceedings.   28
       
Item 1A. Risk Factors.   28
       
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.   28
       
Item 3. Defaults Upon Senior Securities.   29
       
Item 4. Mine Safety Disclosures.   29
       
Item 5. Other Information.   29
       
Item 6. Exhibits.   30
       
SIGNATURES   31

 

i

 

 

Unless otherwise stated in this Report (as defined below), or the context otherwise requires, references to:

 

  ● “2024 Annual Report” are to our Annual Report on Form 10-K for the fiscal year ended December 31, 2024, as filed with the SEC (as defined below) on March 31, 2025;

 

  ● “2025 Annual Report” are to our Annual Report on Form 10-K for the fiscal year ended December 31, 2025, as filed with the SEC on March 27, 2026;

 

  ● “2026 EGM” are to our extraordinary general meeting in lieu of an annual general meeting of shareholders held on May 7, 2026;
     
  ● “2026 First Quarter Form 10-Q” are to our Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2026, as filed with the SEC on May 15, 2026;

 

  ● “2026 Redemptions” are to the 22,447,232 Public Shares whose holders properly exercised their right to redeem their Public Shares for cash at a redemption price of approximately $10.79 per share in connection with the approval of the Extension Amendment Proposal (as defined below);

 

  ● “2026 Second Quarter Form 10-Q” are to our Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2026, as filed with the SEC on August 14, 2026;

 

  ● “Acquisition” are to our acquisition of 100% of the outstanding equity and equity equivalents of AIT (as defined below);

 

  ● “AIT” are to American Industrial Technologies, Inc., a Nevada corporation;

 

  ● “Amended and Restated Articles” are to our Amended and Restated Memorandum and Articles of Association, as amended and currently in effect;

 

  ● “ASU” are to the FASB (as defined below) Accounting Standards Update;

 

  ● “Binding LOI” are to the binding letter of intent with AIT, dated October 2, 2026, which superseded the LOI (as defined below);

 

  ● “Board of Directors” or “Board” are to our board of directors;

 

  ● “Business Combination” are to a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses;

 

  ● “Cantor” are to Cantor Fitzgerald & Co., the representative of the Underwriters (as defined below);

 

  ● “Certifying Officers” are to our Chief Executive Officer and Chief Financial Officer, together;

 

  ● “Class A Ordinary Shares” are to our Class A ordinary shares, par value $0.0001 per share;

 

  ● “Class B Ordinary Shares” are to our Class B ordinary shares, par value $0.0001 per share;

 

  ● “Combination Period” are to the (i) period from the closing of the Initial Public Offering (as defined below) to July 12, 2027 (or such earlier date as determined by the Board), as extended by the Extension Amendment Proposal (as defined below), that we have to consummate an initial Business Combination, or (ii) such other period during which we must consummate an initial Business Combination pursuant to an amendment to the Amended and Restated Articles and consistent with applicable laws, regulations and stock exchange rules;

 

  ● “Company,” “our,” “we” or “us” are to SIM Acquisition Corp. I, a Cayman Islands exempted company;

 

  ● “Continental” are to Continental Stock Transfer & Trust Company, trustee of our Trust Account (as defined below) and warrant agent of our Warrants (as defined below);

 

ii

 

 

  ● “Conversion” are to the conversion of 3,000,000 Class B Ordinary Shares held by our Sponsor into 3,000,000 Class A Ordinary Shares on a one-for-one basis on May 11, 2026;
   
  ● “Dominari” are to Dominari Holdings Inc.;
     
  ● “Exchange Act” are to the Securities Exchange Act of 1934, as amended;

 

  ● “Extension Amendment Proposal” are to the proposal at the 2026 EGM to amend the Amended and Restated Articles to extend the Combination Period from July 11, 2026 to July 12, 2027 (or such earlier date as determined by the Board);

 

  ● “FASB” are to the Financial Accounting Standards Board;
     
  ● “Fee Reduction Agreement” are to the agreement among us, our Sponsor and Cantor dated January 28, 2026;

 

  ● “Founder Shares” are to the (i) Class B Ordinary Shares initially purchased by our Sponsor prior to the Initial Public Offering and (ii) Class A Ordinary Shares that will be issued upon the automatic conversion of the Class B Ordinary Shares (x) at the time of our Business Combination as described in the IPO Registration Statement (as defined below) or (y) earlier at the option of the holders thereof, as described in the IPO Registration Statement; (for the avoidance of doubt, such Class A Ordinary Shares will not be “Public Shares” (as defined below));

 

  ● “GAAP” are to the accounting principles generally accepted in the United States of America;

 

  ● “Initial Public Offering” or “IPO” are to the initial public offering that we consummated on July 11, 2024;

 

  ● “Investment Company Act” are to the Investment Company Act of 1940, as amended;

 

  ● “IPO Promissory Note” are to that certain unsecured promissory note in the principal amount of up to $300,000 issued to our Sponsor on March 8, 2024;

 

  ● “IPO Registration Statement” are to the Registration Statement on Form S-1 initially filed with the SEC on June 17, 2024, as amended, and declared effective on July 9, 2024 (File No. 333-280274);

 

  ● “Letter Agreement” are to the Letter Agreement, dated July 9, 2024, which we entered into with our Sponsor and our directors and officers;
     
  ● “LOI” are to the non-binding letter of intent, dated April 26, 2026, between us and AIT;
     
  ● “Management” or our “Management Team” are to our executive officers and directors;

 

  ● “Nasdaq” are to The Nasdaq Stock Market LLC;

 

  ● “Nasdaq 36-Month Requirement” are to the requirement pursuant to the Nasdaq Rules (as defined below) that a SPAC (as defined below) must complete one or more Business Combinations within 36 months following the effectiveness of its initial public offering registration statement;

 

  ● “Nasdaq Rules” are to the continued listing rules of Nasdaq, as they exist as of the date of the Report;

 

  ● “Option Units” are to the 3,000,000 units that were purchased by the Underwriters pursuant to the full exercise of the Over-Allotment Option (as defined below);

 

  ● “Ordinary Shares” are to the Class A Ordinary Shares and the Class B Ordinary Shares, together;
     
  ● “Original Deferred Underwriting Fee” are to the additional aggregate fee of up to $10,950,000 to which the Underwriters are entitled that is payable only upon our completion of the initial Business Combination;

 

iii

 

 

  ● “Over-Allotment Option” are to the 45-day option that the Underwriters had to purchase up to an additional 3,000,000 Option Units to cover over-allotments, if any, pursuant to the Underwriting Agreement (as defined below), which was fully exercised;

 

  ● “Private Placement” are to the private placement of Private Placement Warrants (as defined below) that occurred simultaneously with the closing of our Initial Public Offering, pursuant to the Private Placement Warrants Purchase Agreements (as defined below);

 

  ● “Private Placement Warrants” are to the warrants purchased by our Sponsor and Cantor in the Private Placement, all of which are now held by our Sponsor;

 

  ● “Private Placement Warrants Purchase Agreements” are to the Private Placement Warrants Purchase Agreements, dated July 9, 2024, which we entered into with the Sponsor and Cantor, respectively;

 

  ● “Public Shareholders” are to the holders of our Public Shares, including our Sponsor and Management Team to the extent our Sponsor and/or the members of our Management Team purchase Public Shares, provided that our Sponsor’s and each member of our Management Team’s status as a “Public Shareholder” will only exist with respect to such Public Shares;

 

  ● “Public Shares” are to the Class A Ordinary Shares included as part of the Units (as defined below) (whether they were purchased in our Initial Public Offering or thereafter in the open market);

 

  ● “Public Warrants” are to the redeemable warrants included as part of the Units (whether they were subscribed for in our Initial Public Offering or purchased in the open market);
     
  ● “Reduced Deferred Fee” are to a non-refundable cash fee equal to 1.5% of the aggregate amount delivered from the Trust Account upon the closing of our initial Business Combination that is payable to Cantor pursuant to the Fee Reduction Agreement;

 

  ● “Report” are to this Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2026;

 

  ● “SEC” are to the U.S. Securities and Exchange Commission;

 

  ● “Securities Act” are to the Securities Act of 1933, as amended;

 

  ● “SPAC” are to a special purpose acquisition company;

 

  ● “Sponsor” are to SIM Sponsor 1 LLC, a Delaware limited liability company;

 

  ● “Trust Account” are to the U.S.-based trust account in which funds from the net proceeds of the sale of the Units in the Initial Public Offering and the Private Placement Warrants in the Private Placement were initially placed following the closing of the Initial Public Offering;

 

  ● “Underwriters” are to the several underwriters of the Initial Public Offering, collectively;

 

  ● “Underwriting Agreement” are to the Underwriting Agreement, dated July 9, 2024, which we entered into with Cantor, as representative of the Underwriters;

 

  ● “Units” are to the units sold in our Initial Public Offering, with each Unit consisting of one Public Share and one-half of one Public Warrant;

 

  ● “Warrants” are to the Private Placement Warrants and the Public Warrants, together;

 

  ● “WCL Promissory Note” are to that certain unsecured promissory note issued by us to the Sponsor on March 18, 2026 in the aggregate principal amount of up to $1,500,000, increased to up to $2,000,000 on November 13, 2026, in connection with the Working Capital Loans (as defined below); and
     
  ● “Working Capital Loans” are to funds that, in order to provide working capital or finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor or certain of our directors and officers may, but are not obligated to, loan us.

 

iv

 

 

PART I – FINANCIAL INFORMATION

 

Item 1. Financial Statements.

 

SIM ACQUISITION CORP. I

CONDENSED BALANCE SHEETS

AS OF SEPTEMBER 30, 2026 (UNAUDITED) AND DECEMBER 31, 2025

 

   

September 30,

2026

    December 31,
2025
 
    (Unaudited)        
ASSETS            
Current Assets            
Cash   $ 280,224     $ 65,427  
Prepaid expenses     192,421       205,000  
Total Current Assets     472,645       270,427  
Cash and marketable securities held in Trust Account     6,168,416       245,118,303  
Total Assets   $ 6,641,061     $ 245,388,730  
LIABILITIES, CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION, AND SHAREHOLDERS’ DEFICIT                
Current liabilities                
Accounts payable and accrued expenses   $ 196,922     $ 304,592  
Promissory Note - Sponsor, net     1,500,309          
Due to Sponsor     38,158          
Total Current Liabilities     1,735,389       304,592  
                 
Long term liabilities                
Original Deferred Underwriting Fee     -       10,950,000  
Total Long Term Liabilities     -       10,950,000  
Total Liabilities     1,735,389       11,254,592  
                 
COMMITMENTS AND CONTINGENCIES (Note 7)                
Class A Ordinary Shares subject to possible redemption, 552,768 and 23,000,000 shares at redemption value of $10.98 and $10.65 per share as of September 30, 2026 and December 31, 2025, respectively     6,068,416       245,018,303  
                 
Shareholders’ Deficit                
Preference shares, $0.0001 par value, 5,000,000 shares authorized; none issued or outstanding as of September 30, 2026 and December 31, 2025     -       -  
Class A Ordinary Shares, $0.0001 par value, 500,000,000 shares authorized; 3,000,000 shares issued and outstanding as of September 30, 2026 and none issued or outstanding as of December 31, 2025 (excluding 552,768 and 23,000,000 Class A Ordinary Shares subject to possible redemption as of September 30, 2026 and December 31, 2025, respectively)     300       -  
Class B Ordinary Shares, $0.0001 par value, 50,000,000 shares authorized; 4,666,667 and 7,666,667 shares issued and outstanding as of September 30, 2026 and December 31, 2025, respectively     467       767  
Accumulated Deficit     (1,163,511 )     (10,884,932 )
Total Shareholders’ Deficit     (1,162,744 )     (10,884,165 )
TOTAL LIABILITIES, CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION, AND SHAREHOLDERS’ DEFICIT   $ 6,641,061     $ 245,388,730  

 

The accompanying notes are an integral part of these unaudited condensed financial statements.

 

1

 

 

SIM ACQUISITION CORP. I

UNAUDITED CONDENSED STATEMENTS OF OPERATIONS

FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2026 AND 2025

 

    For the
three months
ended
September 30,
    For the
three months
ended
September 30,
    For the
nine months
ended
September 30,
    For the
nine months
ended
September 30,
 
    2026     2025     2026     2025  
General and administrative expenses   $ (425,843 )   $ (258,011 )   $ (1,153,269 )   $ (681,018 )
Loss from Operations     (425,843 )     (258,011 )     (1,153,269 )     (681,018 )
                                 
Other income (expense)                                
Interest earned on cash and marketable securities held in Trust Account     55,853       2,510,176       3,225,584       7,453,481  
Interest expense on Promissory Note - Sponsor     (43,578 )     -       (75,310 )     -  
Total other income (expense), net     12,275       2,510,176       3,150,274       7,453,481  
                                 
Net income (loss)   $ (413,568 )   $ 2,252,165     $ 1,997,005     $ 6,772,463  
                                 
Weighted average shares outstanding, Class A Ordinary Shares subject to possible redemption     552,768       23,000,000       10,995,253       23,000,000  
Basic and Diluted Net Income (Loss) per share, Class A Ordinary Shares Subject To Possible Redemption   $ (0.05 )   $ 0.07     $ 0.11     $ 0.22  
                                 
Weighted average shares outstanding, non-redeemable Class A Ordinary Shares and Class B Ordinary Shares     7,666,667       7,666,667       7,666,667       7,666,667  
Basic and Diluted Net Income (Loss) per share, Non-Redeemable Class A Ordinary Shares and Class B Ordinary Shares   $ (0.05 )   $ 0.07     $ 0.11     $ 0.22  

 

The accompanying notes are an integral part of these unaudited condensed financial statements.

 

2

 

 

SIM ACQUISITION CORP. I

UNAUDITED CONDENSED STATEMENTS OF CHANGES IN SHAREHOLDERS’ DEFICIT

FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2026 AND 2025

 

    Class A
Ordinary Shares
    Class B
Ordinary Shares
    Additional
Paid-in
    Accumulated     Total
Shareholders’
 
    Shares     Amount     Shares     Amount     Capital     Deficit     Deficit  
Balance - January 1, 2026     -     $ -       7,666,667     $ 767     $             -     $ (10,884,932 )   $ (10,884,165 )
Waiver of Original Deferred Underwriting Fee     -       -       -       -       -       10,950,000       10,950,000  
Accretion for Class A Ordinary Shares subject to redemption amount     -       -       -       -       -       (2,155,309 )     (2,155,309 )
Net Income     -       -       -       -       -       2,028,399       2,028,399  
Balance - March 31, 2026     -     $ -       7,666,667     $ 767     $ -     $ (61,842 )   $ (61,075 )
Conversion of Class B Ordinary Shares to Class A Ordinary Shares     3,000,000       300       (3,000,000 )     (300 )     -       -       -  
Accretion for Class A Ordinary Shares subject to redemption amount     -       -       -       -       -       (1,014,422 )     (1,014,422 )
Net Income     -       -       -       -       -       382,174       382,174  
Balance - June 30, 2026     3,000,000     $ 300       4,666,667     $ 467     $ -     $ (694,090 )   $ (693,323 )
Accretion for Class A Ordinary Shares subject to redemption amount     -       -       -       -       -       (55,853 )     (55,853 )
Net Loss     -       -       -       -       -       (413,568 )     (413,568 )
Balance - September 30, 2026     3,000,000     $ 300       4,666,667     $ 467     $ -     $ (1,163,511 )   $ (1,162,744 )
                                                         
Balance - January 1, 2025     -     $ -       7,666,667     $ 767     $ -     $ (9,879,091 )   $ (9,878,324 )
Accretion for Class A Ordinary Shares subject to redemption amount     -       -       -       -       -       (2,464,218 )     (2,464,218 )
Net Income     -       -       -       -       -       2,222,746       2,222,746  
Balance - March 31, 2025     -     $ -       7,666,667     $ 767     $ -     $ (10,120,563 )   $ (10,119,796 )
Accretion for Class A Ordinary Shares subject to redemption amount     -       -       -       -       -       (2,479,087 )     (2,479,087 )
Net Income     -       -       -       -       -       2,297,552       2,297,552  
Balance - June 30, 2025     -     $ -       7,666,667     $ 767     $ -     $ (10,302,098 )   $ (10,301,331 )
Accretion for Class A Ordinary Shares subject to redemption amount     -       -       -       -       -       (2,510,176 )     (2,510,176 )
Net Income     -       -       -       -       -       2,252,165       2,252,165  
Balance - September 30, 2025     -     $ -       7,666,667     $ 767     $ -     $ (10,560,109 )   $ (10,559,342 )

 

The accompanying notes are an integral part of these unaudited condensed financial statements.

 

3

 

 

SIM ACQUISITION CORP. I

UNAUDITED CONDENSED STATEMENTS OF CASH FLOWS

FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2026 AND 2025

 

    For the
nine months
ended
September 30,
2026
    For the
nine months
ended
September 30,
2025
 
Cash Flows from Operating Activities            
Net income   $ 1,997,005     $ 6,772,463  
Adjustments to reconcile net income to net cash used in operating activities                
Interest earned on cash and marketable securities held in Trust Account     (3,225,584 )     (7,453,481 )
Non-cash interest on Promissory Note - Sponsor (paid-in-kind interest and amortization of original issue discount)     75,310       -  
Changes in operating assets and liabilities                
Prepaid expenses     12,579       142,200  
Accounts payable and accrued expenses     (107,670 )     10,878  
Net cash used in operating activities     (1,248,360 )     (527,940 )
Cash Flows from Investing Activities                
Cash withdrawn from Trust Account in connection with redemption of Class A Ordinary Shares     242,175,471       -  
Net cash provided by investing activities     242,175,471       -  
Cash Flows from Financing Activities                
Proceeds from Promissory Note - Sponsor, net of original issue discount     1,424,999       -  
Advance from Sponsor in excess of second draw on Promissory Note - Sponsor     38,158       -  
Redemption of Class A Ordinary Shares     (242,175,471 )     -  
Net cash used in financing activities     (240,712,314 )     -  
Net increase (decrease) in cash     214,797       (527,940 )
Cash at beginning of the period     65,427       697,085  
Cash at end of the period   $ 280,224     $ 169,145  
                 
Supplemental disclosure of non-cash financing activities                
Waiver of Original Deferred Underwriting Fee   $ 10,950,000     $ -  
Paid-in-kind interest on Promissory Note - Sponsor     56,355       -  

 

The accompanying notes are an integral part of these unaudited condensed financial statements.

 

4

 

 

SIM ACQUISITION CORP. I

NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026

 

NOTE 1 – DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS

 

Organization and General

 

SIM Acquisition Corp. I (the “Company”) was incorporated as a Cayman Islands exempted company on January 29, 2024. The Company was incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”).

 

As of September 30, 2026, the Company had not commenced any operations. All activity for the period from inception to September 30, 2026, relates to the Company’s formation and the Initial Public Offering (as defined below) and the search for a prospective target for its Business Combination. The Company will not generate any operating revenues until after the completion of its Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income on cash and cash equivalents from the proceeds derived from the Initial Public Offering. The Company has selected December 31 as its fiscal year end.

 

Sponsor and Initial Public Offering

 

The Company’s sponsor is SIM Sponsor 1 LLC, a Delaware limited liability company (the “Sponsor”).

 

The Registration Statement on Form S-1 for the Initial Public Offering, initially filed with the U.S. Securities and Exchange Commission (the “SEC”) on June 17, 2024, as amended (File No. 333-280274), was declared effective on July 9, 2024 (the “IPO Registration Statement”). On July 11, 2024, the Company consummated the Initial Public Offering of 23,000,000 units (each a “Unit” and collectively, the “Units”) at $10.00 per Unit, which included the full exercise of the Over-Allotment Option (as defined in Note 7) in the amount of 3,000,000 Units (the “Option Units”) at $10.00 per Option Unit, generating gross proceeds of $230,000,000 (the “Initial Public Offering”), as discussed in Note 3. Each Unit consists of one Class A ordinary share of the Company, par value $0.0001 per share (the “Class A Ordinary Shares” and with respect to the Class A Ordinary Shares included in the Units, the “Public Shares”), and one-half of one redeemable warrant of the Company (each, a “Public Warrant”), with each whole Public Warrant entitling the holder thereof to purchase one Class A Ordinary Share for $11.50 per share.

 

Simultaneously with the closing of the Initial Public Offering, the Company completed the private sale of an aggregate of 6,000,000 warrants (the “Private Placement Warrants,” and together with the Public Warrants, the “Warrants”), to the Sponsor and Cantor Fitzgerald & Co. (“Cantor”), the representative of the underwriters of the Initial Public Offering (collectively, the “Underwriters”), at a price of $1.00 per Private Placement Warrant in a private placement that closed simultaneously with the Initial Public Offering (the “Private Placement”). Of those 6,000,000 Private Placement Warrants, the Sponsor purchased 4,000,000 Private Placement Warrants and Cantor purchased 2,000,000 Private Placement Warrants. Each whole Private Placement Warrant entitles the holder to purchase one Class A Ordinary Share at $11.50 per share. On January 28, 2026, the Sponsor acquired the 2,000,000 Private Placement Warrants held by Cantor, and all 6,000,000 Private Placement Warrants are now held by the Sponsor (see “Sponsor Acquisition” below).

 

Transaction costs amounted to $15,427,616, consisting of $4,000,000 of cash underwriting fee, $10,950,000 of deferred underwriting fee (the “Original Deferred Underwriting Fee”), and $477,616 of other offering costs (see Note 7 for the Fee Reduction Agreement, under which the Original Deferred Underwriting Fee is no longer payable).

 

Sponsor Acquisition

 

On January 28, 2026, certain accredited investors (the “Buyers”) acquired all of the membership interests in the Sponsor owned by the non-managing members of the Sponsor pursuant to a securities purchase agreement. Simultaneously with such transaction, the Buyers also acquired all of the membership interests of Conroy Partners LLC, the managing member of the Sponsor, pursuant to a membership purchase agreement. As a result of the foregoing transactions, the Buyers own all of the membership interests in the Sponsor. The Sponsor also acquired from Cantor 2,000,000 Private Placement Warrants owned by Cantor pursuant to a securities purchase agreement.

 

5

 

 

On January 28, 2026, in connection with the consummation of transactions contemplated above (the “Sponsor Acquisition”), Erich Spangenberg resigned as the Chairman of the Company’s board of directors (the “Board of Directors” or the “Board”) and as the Company’s Chief Executive Officer, effective as of the closing of the Sponsor Acquisition. Delos M. Cosgrove, MD and Vincent Capone resigned as directors of the Board and as members of the Audit and Compensation Committees of the Board, effective as of the closing of the Sponsor Acquisition.

 

On January 28, 2026, in connection with the Sponsor Acquisition, Christopher Devall was appointed as the Company’s Chief Executive Officer. In addition, Anthony Hayes (as Chairman), Jarrett Gorlin, Matthew Saker, and Kyle Haug were appointed to serve on the Board of Directors, which changes became effective on March 7, 2026.

 

Letters of Intent

 

On April 26, 2026, the Company entered into a non-binding Letter of Intent (the “LOI”) with American Industrial Technologies, Inc., a Nevada corporation (“AIT”) for its acquisition (“Acquisition”) of 100% of the outstanding equity and equity equivalents of AIT upon the terms and conditions to be set forth in certain definitive documents and negotiations.

 

Among other segments, AIT operates Q1, a leader in telecommunications that has evolved into a fully integrated platform spanning manufacturing, logistics, distribution, and connected device ecosystems. Building on its deep relationships with Tier 1 and Tier 2 carriers, AIT has scaled a robust Third-Party Logistics and Fourth-Party Logistics and e-commerce infrastructure that supports global distribution across the United States, Europe, and Latin America.

 

On August 13, 2026, the LOI was extended until October 31, 2026. On October 2, 2026, the Company and AIT entered into a binding letter of intent that superseded the LOI in its entirety (see Note 10). As of the date of this Report, the parties had not executed a definitive business combination agreement.

 

Extension of the Combination Period and 2026 Redemptions

 

On May 7, 2026, the Company held the 2026 EGM to approve, among other things, the Extension Amendment Proposal to amend the Amended and Restated Articles to extend the Combination Period from July 11, 2026 to July 12, 2027 (or such earlier date as determined by the Board). In connection with the vote to approve the Extension Amendment Proposal, Public Shareholders holding 22,447,232 Public Shares (after giving effect to withdrawals of redemptions) exercised their right to redeem such Public Shares for cash at a redemption price of approximately $10.79 per Public Share, for an aggregate redemption amount of $242,175,471 in the 2026 Redemptions, which was paid from the Trust Account in May 2026. Following the 2026 Redemptions, 552,768 Public Shares remained issued and outstanding.

 

The Trust Account

 

Upon consummation of the Initial Public Offering, the Company’s management team (“Management”) initially placed an aggregate of $230,000,000 of the proceeds from the Units sold in the Initial Public Offering and the proceeds of the Private Placement of the Private Placement Warrants, in a United States-based trust account (the “Trust Account”) and invested the proceeds in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act of 1940, as amended (the “Investment Company Act”). The proceeds will be held in the Trust Account until the earlier of (i) the consummation of the Company’s Business Combination (ii) the redemption of any Ordinary Shares (as defined in Note 2) included in the Units being sold in the Initial Public Offering that have been properly tendered in connection with a shareholder vote to amend the Company’s amended and restated memorandum and articles of association (the “Amended and Restated Articles”) to modify the substance or timing of its obligation to redeem 100% of such Ordinary Shares if it does not complete the Business Combination by July 12, 2027 and (iii) the Company’s failure to consummate a Business Combination within the prescribed time. Placing funds in the Trust Account may not protect those funds from third party claims against the Company. Although the Company will seek to have all vendors, service providers (except the Company’s independent registered public accounting firm), prospective target businesses or other entities it engages, execute agreements with the Company waiving any claim of any kind in or to any monies held in the Trust Account, there is no guarantee that such persons will execute such agreements. There can be no assurance that it will be able to satisfy those obligations should they arise. The remaining net proceeds (not held in the Trust Account) will be used to pay for business, legal and accounting due diligence on prospective acquisitions and continuing general and administrative expenses. Additionally, certain interest earned on the Trust Account balance may be released to the Company to pay the Company’s tax obligations and trust administration expenses.

 

6

 

 

Initial Business Combination

 

Management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering, although substantially all of the net proceeds of the Initial Public Offering are intended to be generally applied toward consummating a Business Combination. The Business Combination must occur with one or more target businesses that together have an aggregate fair market value of at least 80% of the assets held in the Trust Account (excluding the Reduced Deferred Fee (as defined in Note 7) and taxes payable on income earned on the Trust Account) at the time of the agreement to enter into the Business Combination. Furthermore, there is no assurance that the Company will be able to successfully effect a Business Combination.

 

The Company, after signing a definitive agreement for the acquisition of a target business, is required to provide holders of the Public Shares (“Public Shareholders”) with the opportunity to redeem their Public Shares for a pro rata share of the Trust Account. The holders of the Founder Shares (as defined in Note 5) will agree to vote any Ordinary Shares they then hold in favor of any proposed Business Combination and will waive any conversion rights with respect to these Ordinary Shares pursuant to the letter agreement, dated July 9, 2024, by and among the Company, the Sponsor and the Company’s officers and directors (the “Letter Agreement”).

 

In connection with any proposed Business Combination, the Company will seek shareholder approval of a Business Combination at a meeting called for such purpose at which Public Shareholders may seek to redeem their Public Shares, regardless of whether they vote for or against the proposed Business Combination. Alternatively, the Company may conduct a tender offer and allow redemptions in connection therewith. If the Company seeks shareholder approval of a Business Combination, any Public Shareholder voting either for or against such proposed Business Combination or not voting at all will be entitled to demand that his Public Shares be redeemed for a full pro rata portion of the amount then in the Trust Account (initially $10.00 per share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company or necessary to pay its taxes and trust administration expenses).

 

Pursuant to the Amended and Restated Articles, if the Company is unable to complete its Business Combination by July 12, 2027 (the “Combination Period”) and such date is not further extended by shareholders, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem 100% of the outstanding Public Shares at a per share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned thereon (less taxes payable and up to $100,000 of interest income to pay dissolution expenses) and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining holders of Ordinary Shares and the Board of Directors, liquidate and dissolve. The Warrants will expire on liquidation of the Trust Account and the holders of Warrants will receive no proceeds in connection with the liquidation. The holders of the Founder Shares will not participate in any redemption distribution with respect to their Founder Shares.

 

As of September 30, 2026, the Class A Ordinary Shares subject to possible redemption were carried at a redemption value of $10.98 per Public Share, which is the amount held in the Trust Account less up to $100,000 of interest that may be used to pay dissolution expenses (see Note 2); the pro rata amount held in the Trust Account was approximately $11.16 per Public Share, which is the amount a Public Shareholder would receive upon redemption of a Public Share in connection with a shareholder vote on a Business Combination. The proceeds deposited in the Trust Account could, however, become subject to claims of the Company’s creditors that are in preference to the claims of the Company’s shareholders. In addition, if the Company is forced to file a bankruptcy or winding up petition or an involuntary bankruptcy or winding up petition is filed against it that is not dismissed, the proceeds held in the Trust Account could be subject to applicable bankruptcy or insolvency law, and may be included in its bankruptcy or insolvency estate and subject to the claims of third parties with priority over the claims of the Company’s Public Shareholders. Therefore, the actual per-share redemption price may be less than the pro rata amount held in the Trust Account.

 

7

 

 

Risks and Uncertainties

 

The Company’s ability to complete an initial Business Combination may be adversely affected by various factors, many of which are beyond the Company’s control. The Company’s ability to consummate an initial Business Combination could be impacted by, among other things, changes in laws or regulations, downturns in the financial markets or in economic conditions, inflation, fluctuations in interest rates, increases in tariffs, supply chain disruptions, declines in consumer confidence and spending, public health considerations, and geopolitical instability, such as the military conflicts in Ukraine, between the United States, Israel and Iran and others in the Middle East, and Southwest Asia or other armed hostilities. The Company cannot at this time predict the likelihood of one or more of the above events, their duration or magnitude or the extent to which they may negatively impact the Company’s ability to complete an initial Business Combination.

 

Liquidity and Capital Sources and Going Concern

 

As of September 30, 2026 and December 31, 2025, the Company had a cash balance of $280,224 and $65,427, respectively, and a working capital deficit of $1,262,744 and $34,165, respectively. Further, the Company has incurred and expects to continue to incur significant costs in pursuit of a Business Combination. In connection with the Company’s assessment of going concern considerations in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 205-40, “Presentation of Financial Statements—Going Concern,” Management has determined that the mandatory liquidation and subsequent dissolution raises substantial doubt about the Company’s ability to continue as a going concern. The accompanying unaudited condensed financial statements do not include any adjustments that may be necessary if the Company is unable to continue as a going concern. It is uncertain that the company will be able to consummate a Business Combination by July 12, 2027. If a Business Combination is not consummated by this date, there will be a mandatory liquidation and subsequent dissolution of the Company. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after July 12, 2027. In addition, the Company’s cash balance does not exceed its current budgeted operating requirements, and Management has concluded that this indicates the Company will not have sufficient liquidity to meet its obligations as they become due within one year after the date the accompanying unaudited condensed financial statements are issued. Management plans to address these conditions by consummating the proposed Business Combination with AIT (see Note 10) and, if needed, by drawing the $500,001 of principal available under the WCL Promissory Note, as amended on November 13, 2026, and by obtaining additional Working Capital Loans from the Sponsor or its affiliates, which are under no obligation to provide them. These plans are not within the Company’s control and are not considered probable of alleviating the substantial doubt.

 

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation

 

The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of Management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.

 

The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2025, as filed with the SEC on March 27, 2026. The interim results for the three and nine months ended September 30, 2026 are not necessarily indicative of future performance.

 

Reclassifications

 

Certain amounts previously reported for the three months ended March 31, 2026 and June 30, 2026 have been reclassified to conform to the current period presentation. Interest on the WCL Promissory Note of $31,732 (paid-in-kind interest of $24,115 and amortization of original issue discount of $7,617), previously included in general and administrative expenses, is now presented as interest expense on Promissory Note - Sponsor, and the related non-cash interest previously included in financing activities is now presented as a non-cash adjustment in operating activities. These changes had no effect on previously reported net income, net income per share, total assets or shareholders’ deficit.

 

8

 

 

Emerging Growth Company

 

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended (the “Securities Act”), as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.

 

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make the comparison of the accompanying unaudited condensed financial statements with those of another public company that is neither an (i) emerging growth company nor (ii) emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

 

Cash

 

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company has $280,224 in cash and did not have any cash equivalents as of September 30, 2026. As of December 31, 2025, the Company had $65,427 in cash and did not have any cash equivalents.

 

Marketable Securities and Cash Held in Trust Account

 

At September 30, 2026 and December 31, 2025, the assets held in the Trust Account, amounting to $6,168,416 and $245,118,303, respectively, were held in a money market fund (BlackRock Liquidity Treasury Trust Fund) in an account at Morgan Stanley that invests entirely in U.S. Treasury securities and meets the conditions under Rule 2a-7 under the Investment Company Act.

 

Offering Costs

 

The Company complies with the requirements of FASB Accounting Standards Codification (“ASC”) Topic 340-10-S99, “Other Assets and Deferred Costs,” and SEC Staff Accounting Bulletin Topic 5A, “Expenses of Offering.” Deferred offering costs consist principally of professional and registration fees that are related to the Initial Public Offering. FASB ASC Topic 470-20, “Debt with Conversion and Other Options,” addresses the allocation of proceeds from the issuance of convertible debt into its equity and debt components. The Company applied this guidance to allocate Initial Public Offering proceeds from the Units between Public Shares and Public Warrants, using the residual method by allocating Initial Public Offering proceeds first to the assigned value of the Public Warrants and then to the Public Shares. Offering costs allocated to Class A Ordinary Shares were charged to temporary equity, and offering costs allocated to the Public Warrants and Private Placement Warrants were charged to shareholders’ deficit as Public Warrants and Private Placement Warrants after Management’s evaluation are accounted for under equity treatment.

 

9

 

 

Concentration of Credit Risk

 

Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation maximum of $250,000. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations, and cash flows.

 

Financial Instruments

 

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under FASB ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying condensed balance sheets, primarily due to their short-term nature.

 

Fair Value Measurements

 

“Fair value” is defined as the price that would be received for sale of an asset or paid for transfer of a liability in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:

 

  ● “Level 1”, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;

 

  ● “Level 2”, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and

 

  ● “Level 3”, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.

 

Use of Estimates

 

The preparation of the accompanying unaudited condensed financial statements in conformity with GAAP requires Management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities and the reported amounts of expenses during the reporting period.

 

Making estimates requires Management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the accompanying unaudited condensed financial statements, which Management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Actual results could differ from those estimates.

 

Net Income Per Ordinary Share

 

The Company complies with the accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” The Company has two classes of shares for purposes of computing net income (loss) per share: (i) redeemable Class A Ordinary Shares and (ii) non-redeemable Class A Ordinary Shares and Class B ordinary shares, par value $0.0001 per share (the “Class B Ordinary Shares,” and together with the Class A Ordinary Shares, the “Ordinary Shares”). Income and losses are shared pro rata between the Ordinary Shares. Net income per Ordinary Share is calculated by dividing the net income by the weighted average number of Ordinary Shares outstanding for the respective period. Diluted net income per Ordinary Share attributable to holders of Ordinary Shares adjusts the basic net income per share attributable to such holders and the weighted average number of Ordinary Shares outstanding for the potentially dilutive impact of outstanding Warrants. However, because the exercise of the Warrants is contingent upon the occurrence of future events, diluted income per Ordinary Share is the same as basic income per ordinary share for the periods presented.

 

10

 

 

Consistent with FASB ASC Topic 480-10-S99-3A, SEC Staff Announcement: Classification and Measurement of Redeemable Securities (the “Redeemable Securities Guidance”), accretion of the Class A Ordinary Shares subject to possible redemption is excluded from net income (loss) per Ordinary Share because the redemption value approximates fair value.

 

The following table reflects the calculation of basic and diluted net income per Ordinary Share:

 

    For the three months ended
September 30, 2026
    For the three months ended
September 30, 2025
 
    Redeemable
Class A
Ordinary
Shares
    Non-Redeemable
Class A and
Class B
Ordinary
Shares
    Redeemable
Class A
Ordinary
Shares
    Non-Redeemable
Class B
Ordinary
Shares
 
Basic and Diluted net income per share:                        
Numerator:                        
Allocation of net income (loss)   $ (27,813 )   $ (385,755 )   $ 1,689,124     $ 563,041  
                                 
Denominator:                                
Weighted-average shares outstanding     552,768       7,666,667       23,000,000       7,666,667  
Basic and Diluted income (loss) per share   $ (0.05 )   $ (0.05 )   $ 0.07     $ 0.07  

 

    For the nine months ended
September 30, 2026
    For the nine months ended
September 30, 2025
 
    Redeemable
Class A
Ordinary
Shares
    Non-Redeemable
Class A and
Class B
Ordinary
Shares
    Redeemable
Class A
Ordinary
Shares
    Non-Redeemable
Class B
Ordinary
Shares
 
Basic and Diluted net income per share:                        
Numerator:                        
Allocation of net income   $ 1,176,598     $ 820,407     $ 5,079,347     $ 1,693,116  
                                 
Denominator:                                
Weighted-average shares outstanding     10,995,253       7,666,667       23,000,000       7,666,667  
Basic and Diluted income per share   $ 0.11     $ 0.11     $ 0.22     $ 0.22  

 

Income Taxes

 

The Company accounts for income taxes under FASB ASC Topic 740, “Income Taxes” (“ASC 740”), which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statements and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.

 

ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statements recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company’s management determined that the Cayman Islands is the Company’s major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. As of September 30, 2026 and December 31, 2025, there were no unrecognized tax benefits and no amounts accrued for interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.

 

11

 

 

The Company is considered to be an exempted Cayman Islands company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. As such, the Company’s tax provision was zero for the periods presented.

 

Class A Ordinary Shares Subject to Possible Redemption

 

The Public Shares contain a redemption feature which allows for the redemption of such Public Shares in connection with the Company’s liquidation, or if there is a shareholder vote or tender offer in connection with the Company’s initial Business Combination. In accordance with the Redeemable Securities Guidance, the Company classifies Public Shares subject to redemption outside of permanent equity as the redemption provisions are not solely within the control of the Company. The Public Shares sold as part of the Units in the Initial Public Offering were issued with other freestanding instruments (i.e., Public Warrants) and as such, the initial carrying value of the Public Shares are classified as temporary equity and the allocated proceeds are determined in accordance with FASB ASC Topic 470-20, “Debt with Conversion and Other Options.” The Company recognizes changes in redemption value immediately as it occurs and will adjust the carrying value of redeemable shares to equal the redemption value at the end of each reporting period. Immediately upon the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption value. The change in the carrying value of redeemable shares will result in charges against additional paid-in capital (to the extent available) and accumulated deficit. Accordingly, as of September 30, 2026 and December 31, 2025, Class A Ordinary Shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ deficit section of the accompanying unaudited condensed balance sheets. Redemption value is the amount held in the Trust Account less up to $100,000 of interest income that may be used to pay dissolution expenses.

 

At September 30, 2026 and December 31, 2025, the Class A Ordinary Shares subject to possible redemption reflected in the accompanying condensed balance sheets are reconciled in the following table:

 

December 31, 2024   $ 235,222,812  
Plus:        
Accretion of carrying value to redemption value     9,795,490  
Class A Ordinary Shares subject to possible redemption, December 31, 2025   $ 245,018,302  
Plus:        
Waiver of Original Deferred Underwriting Fee payable allocated to Class A Ordinary Shares subject to possible redemption     10,950,000  
Less:        
Remeasurement of carrying value to redemption value     (10,950,000 )
Plus:        
Accretion of carrying value to redemption value     2,155,309  
Class A Ordinary Shares subject to possible redemption, March 31, 2026 (Unaudited)   $ 247,173,611  
Less:        
Redemption of 22,447,232 Class A Ordinary Shares     (242,175,470 )
Plus:        
Accretion of carrying value to redemption value     1,014,422  
Class A Ordinary Shares subject to possible redemption, June 30, 2026 (Unaudited)   $ 6,012,563  
Plus:        
Accretion of carrying value to redemption value     55,853  
Class A Ordinary Shares subject to possible redemption, September 30, 2026 (Unaudited)   $ 6,068,416  

 

Warrant Instruments

 

The Company accounts for the Public Warrants and Private Warrants issued in connection with the Initial Public Offering and the Private Placement in accordance with the guidance contained in FASB ASC Topic 815, “Derivatives and Hedging.” Accordingly, the Company evaluated and classified the warrant instruments under equity treatment at their assigned values.

 

12

 

 

Recent Accounting Standards

 

Management does not believe that there are any recently issued, but not yet effective, accounting standards, which if currently adopted, would have a material effect on the accompanying unaudited condensed financial statements.

 

NOTE 3 – INITIAL Public Offering

 

Pursuant to the Initial Public Offering, on July 11, 2024, the Company sold 23,000,000 Units, including the full exercise by the Underwriters of their Over-Allotment Option in the amount of 3,000,000 Option Units, at a purchase price of $10.00 per Unit. Each Unit consists of one Public Share and one-half of one Public Warrant. Each whole Public Warrant offered in the Initial Public Offering grants the holder thereof to exercise the right to purchase one Class A Ordinary Share for $11.50 per share. Only whole Public Warrants may be exercised. No fractional shares will be issued upon exercise of the Public Warrants. If, upon exercise of the Public Warrants, a holder would be entitled to receive a fractional interest in a share, the Company will, upon exercise, round down to the nearest whole number the number of Class A Ordinary Shares to be issued to the Public Warrant holder.

 

NOTE 4 – PRIVATE PLACEMENT

 

Simultaneously with the closing of the Initial Public Offering, the Sponsor and Cantor purchased an aggregate of 6,000,000 Private Placement Warrants at a price of $1.00 per Private Placement Warrant, or $6,000,000 in the aggregate, in the Private Placement. Of those 6,000,000 Private Placement Warrants, the Sponsor purchased 4,000,000 Private Placement Warrants and Cantor purchased 2,000,000 Private Placement Warrants. Each whole Private Placement Warrant entitles the registered holder to purchase one Class A Ordinary Share at a price of $11.50 per share, subject to adjustment. On January 28, 2026, the Sponsor acquired the 2,000,000 Private Placement Warrants held by Cantor (see Note 1), and all 6,000,000 Private Placement Warrants are held by the Sponsor as of September 30, 2026.

 

The Private Placement Warrants are identical to the Public Warrants sold in the Initial Public Offering except that, so long as they are held by the Sponsor, Cantor or their permitted transferees, the Private Placement Warrants (i) may not (including the Class A Ordinary Shares issuable upon exercise of these Private Placement Warrants), subject to certain limited exceptions, be transferred, assigned or sold by the holders until 30 days after the completion of the Business Combination, (ii) are entitled to registration rights and (iii) with respect to the Private Placement Warrants held by Cantor and/or its designees, are not exercisable for more than five years from the commencement of sales in the Initial Public Offering in accordance with Financial Industry Regulatory Authority Rule 5110(g)(8).

 

NOTE 5 – RELATED PARTY TRANSACTIONS

 

Founder Shares

 

On January 29, 2024, the Sponsor paid $25,000, or approximately $0.003 per share, to cover certain costs in consideration for 5,750,000 Class B Ordinary Shares, par value $0.0001 per share (collectively the “Founder Shares”). In May 2024, the Company effected a share dividend of one-third of one share for each Class B Ordinary Share outstanding, resulting in the Sponsor holding an aggregate of 7,666,667 Founder Shares. All shares and per share data have been restated to reflect this change.

 

In April 2024, the Sponsor transferred 50,000 Founder Shares to each of the Company’s three independent directors for an aggregate of 150,000 Founder Shares, at a price of $0.003 per share. In May 2024, the Company effected a share dividend of one-third of one share for each Class B Ordinary Share outstanding, resulting in the Company’s directors holding an aggregate of 199,998 Founder Shares, or 66,666 each.

 

On September 4, 2025, Janine Grasso resigned as a director of the Board, and as a member of the audit and compensation committees of the Board, effective immediately, and on October 27, 2025, in connection with her resignation, she transferred 60,000 Founder Shares back to the Sponsor. On March 13, 2026, in connection with their resignations as directors on January 28, 2026, Delos M. Cosgrove and Vincent Capone each transferred 60,000 Founder Shares back to the Sponsor. As a result, the Company’s three former independent directors hold an aggregate of 19,998 Founder Shares, or 6,666 each.

 

13

 

 

The transfer of Founder Shares to each of the Company’s three independent directors in April 2024 is in the scope of FASB ASC Topic 718, “Compensation-Stock Compensation” (“ASC 718”). Under ASC 718, stock-based compensation associated with equity-classified awards is measured at fair value upon the grant date. The fair value of the 199,998 Founder Shares transferred to the three directors was $197,998, or $0.99 per share. The Founder Shares were granted subject to a performance condition (i.e., the occurrence of a Business Combination), and compensation expense is recognized only when the performance condition is probable of occurrence under the applicable accounting literature. Following their resignations, each of the three former directors transferred 60,000 Founder Shares back to the Sponsor, for an aggregate of 180,000 Founder Shares, and retained 6,666 Founder Shares, for an aggregate of 19,998 Founder Shares. No compensation expense had been recognized for the Founder Shares returned to the Sponsor and, accordingly, no amount was reversed. The Sponsor’s agreement to permit each former director to retain 6,666 Founder Shares notwithstanding his or her resignation was accounted for as a modification under ASC 718; the retained Founder Shares remain subject to the Business Combination performance condition, and the related compensation cost, measured at the fair value of the retained Founder Shares on the modification date, will be recognized when a Business Combination is considered probable (i.e., upon consummation of a Business Combination). As of September 30, 2026, the Company determined that a Business Combination is not considered probable and, therefore, no stock-based compensation expense has been recognized.

 

Pursuant to the Letter Agreement, the Sponsor and the Company’s officers and directors have agreed to (i) waive their redemption rights with respect to their Founder Shares and Public Shares in connection with the completion of the Business Combination; (ii) waive their redemption rights with respect to their Founder Shares and Public Shares in connection with a shareholder vote to approve an amendment to the Company’s Amended and Restated Articles to modify (A) the substance or timing of the Company’s obligation to allow redemption in connection with the Business Combination or to redeem 100% of the Public Shares if the Company has not consummated a Business Combination within the Combination Period or (B) any other material provisions relating to shareholders’ rights or pre-Business Combination activity; (iii) waive their rights to liquidating distributions from the Trust Account with respect to their Founder Shares if the Company fails to complete the Business Combination within the Combination Period, although they will be entitled to liquidating distributions from the Trust Account with respect to any Public Shares they hold if the Company fails to complete the Business Combination within the Combination Period and to liquidating distributions from assets outside the Trust Account; and (iv) vote any Founder Shares held by them and any Public Shares purchased during or after the Initial Public Offering (including in open market and privately negotiated transactions) in favor of the Business Combination (except that any Public Shares such parties may purchase in compliance with the requirements of Rule 14e-5 under the Exchange Act would not be voted in favor of approving the Business Combination).

 

The Sponsor and the Company’s officers and directors also agreed pursuant to the Letter Agreement, subject to limited exceptions, not to transfer, assign or sell any of their Founder Shares until the earlier to occur of: (i) six (6) months after the completion of the Business Combination or (ii) the date following the completion of the Business Combination on which the Company completes a liquidation, merger, share exchange or other similar transaction that results in all of the Public Shareholders having the right to exchange their Class A Ordinary Shares for cash, securities or other property.

 

Private Placement Warrants

 

The Sponsor and Cantor purchased an aggregate of 6,000,000 Private Placement Warrants at a price of $1.00 per Private Placement Warrant, generating proceeds of $6,000,000 in the Private Placement that closed simultaneously with the closing of the Initial Public Offering. Each Private Placement Warrant is exercisable to purchase one Class A Ordinary Share at $11.50 per share. A portion of the proceeds from the Private Placement Warrants was added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the Private Placement Warrants will expire worthless.

 

14

 

 

The Sponsor and the Company’s officers and directors agreed, subject to limited exceptions, not to transfer, assign or sell any of their Private Placement Warrants until 30 days after the completion of the Business Combination.

 

IPO Promissory Note

 

On March 8, 2024, the Sponsor agreed to loan the Company up to $300,000 to cover expenses related to the Initial Public Offering pursuant to a promissory note (the “IPO Promissory Note”). This loan was non-interest bearing and payable on the earlier of December 31, 2024 or the completion of the Initial Public Offering. As of July 11, 2024, the IPO Promissory Note was repaid in full at the closing of the Initial Public Offering and the IPO Promissory Note is no longer available.

 

Working Capital Loans

 

In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors, may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. The Working Capital Loans made to date are evidenced by the WCL Promissory Note described below, which bears interest and is not convertible into warrants. As described in the IPO Registration Statement, up to $1,500,000 of Working Capital Loans may be convertible, at the lender’s option, into Private Placement Warrants at a price of $1.00 per warrant. As of September 30, 2026 and December 31, 2025, the Company borrowed a total of $1,499,999 and $0, respectively, under Working Capital Loans pursuant to the WCL Promissory Note (as defined below).

 

Promissory Note with Sponsor

 

On March 18, 2026, the Company issued a promissory note in the aggregate principal amount of up to $1,500,000 to the Sponsor (the “WCL Promissory Note”). Pursuant to the WCL Promissory Note, the interest rate is 12.0% per annum, based on the actual number of days elapsed over a 360-day year. The first draw of $736,841 of principal was funded on March 25, 2026 at a 5.0% original issue discount (“OID”) of $36,842, for cash proceeds of $699,999; the second draw, of $763,158 of principal, was funded on August 27, 2026 at an OID of $38,158, for cash proceeds of $725,000; the Sponsor wired $763,158, and the $38,158 excess is due to the Sponsor. The OID is amortized to interest expense on a straight-line basis over the period to July 12, 2027, the end of the Combination Period, which does not differ materially from the interest method. The effective interest rates, including the OID, are approximately 17.3% per annum on the first draw and 19.6% per annum on the second draw. Interest is paid in kind quarterly by adding it to the principal balance. The WCL Promissory Note is due and payable upon the earlier to occur of: (1) the Company’s initial Business Combination, or (2) the Company’s liquidation. On July 31, 2026, the Company delivered a request to the Sponsor to fund a second draw under the WCL Promissory Note, which was funded on August 27, 2026. As a result, $1,499,999 of the $1,500,000 principal amount had been drawn as of September 30, 2026. As of September 30, 2026, the WCL Promissory Note had a face amount of $1,499,999 plus $56,355 of paid-in-kind interest ($1,556,354 in total) and a net carrying value of $1,500,309, reflecting $56,045 of unamortized original issue discount. For the three and nine months ended September 30, 2026, the Company recognized $43,578 and $75,310, respectively, of interest expense on the WCL Promissory Note, consisting of paid-in-kind interest and amortization of the OID, which is presented as interest expense in the accompanying unaudited condensed statements of operations. On November 13, 2026, the WCL Promissory Note was amended to increase its maximum principal amount to $2,000,000 (see Note 10).

 

Administrative Services Agreement

 

The Company paid an aggregate of $10,000 per month to the Sponsor or an affiliate thereof for office space, utilities, and secretarial and administrative support pursuant to an administrative services agreement, dated July 9, 2024, by and between the Company and SIM Management LP, an affiliate of the Sponsor. The Company began incurring such fees on July 9, 2024 and is to continue to incur these fees monthly until the earlier of the completion of the Business Combination or our liquidation. On January 28, 2026, such administrative services agreement was terminated, and any accrued obligations under such agreement were waived.

 

15

 

 

On March 18, 2026, the Company entered into an administrative services agreement with Dominari Holdings Inc. (“Dominari”), pursuant to which Dominari provides office space, utilities and secretarial and administrative support to the Company in exchange for $20,000 per month. Mr. Hayes, the Company’s Chairman, is the Chief Executive Officer of Dominari and Mr. Devall, the Company’s Chief Executive Officer, is the Chief Operating Officer of Dominari. Commencing in May 2026, the $20,000 monthly fee has been paid $10,000 per month to Dominari and $10,000 per month to Torian Investment Advisers LLC, an affiliated entity of Mr. Kutcher, the Company’s Chief Financial Officer. As of September 30, 2026, the Company has paid $140,000 pursuant to this agreement, of which $90,000 was paid to Dominari and $50,000 was paid to such affiliated entity. For the three and nine months ended September 30, 2026, the Company incurred $60,000 and $140,000, respectively, in fees under this agreement, which are included in general and administrative expenses in the accompanying unaudited condensed statements of operations. As of September 30, 2026, no amounts were accrued or prepaid under this agreement.

 

NOTE 6 – SHAREHOLDERS’ deficit

 

Preference Shares 

 

The Company is authorized to issue 5,000,000 preference shares with such designations, voting and other rights and preferences as may be determined from time to time by the Board of Directors. As of September 30, 2026 and December 31, 2025, there were no preference shares issued or outstanding.

 

Class A Ordinary Shares 

 

The Company is authorized to issue 500,000,000 Class A Ordinary Shares with a par value of $0.0001 per share. At September 30, 2026, there were 3,000,000 Class A Ordinary Shares issued and outstanding, excluding 552,768 Class A Ordinary Shares subject to possible redemption. At December 31, 2025, there were no Class A Ordinary Shares issued or outstanding, excluding 23,000,000 Class A Ordinary Shares subject to possible redemption.

 

Class B Ordinary Shares 

 

The Company is authorized to issue 50,000,000 Class B Ordinary Shares with a par value of $0.0001 per share. Holders are entitled to one vote for each Class B Ordinary Share. As of September 30, 2026 and December 31, 2025, there were 4,666,667 and 7,666,667 Class B Ordinary Shares issued and outstanding, respectively (see Note 5).

 

Holders of the Class A Ordinary Shares and holders of the Class B Ordinary Shares will vote together as a single class on all matters submitted to a vote of the Public Shareholders, except as required by law or stock exchange rule; provided that only holders of the Class B Ordinary Share have the right to vote on the appointment of the Board of Directors prior to the initial Business Combination.

 

The Class B Ordinary Share will automatically convert into Class A Ordinary Share at the time of the initial Business Combination on a one-for-one basis (as adjusted). In the case that additional Class A Ordinary Shares or equity-linked securities are issued or deemed issued in connection with the initial Business Combination, the number of Class A Ordinary Shares issuable upon conversion of all Founder Shares will equal, in the aggregate, 25% of the total number of Class A Ordinary Shares outstanding after such conversion (after giving effect to any redemptions of Class A Ordinary Shares by Public Shareholders), including the total number of Class A Ordinary Shares issued, or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of the initial Business Combination, excluding any Class A Ordinary Shares or equity-linked securities exercisable for or convertible into Class A Ordinary Shares issued, or to be issued, to any seller in the initial Business Combination and any Private Placement Warrants issued to the Sponsor and the Company’s officers or directors upon conversion of Working Capital Loans; provided that such conversion of Founder Shares will never occur on a less than one-for-one basis.

 

On May 11, 2026, 3,000,000 Class B Ordinary Shares held by the Sponsor were converted into 3,000,000 Class A Ordinary Shares on a one-for-one basis (the “Conversion”). The Class A Ordinary Shares issued in connection with the Conversion are subject to the same restrictions as applied to the Class B Ordinary Shares prior to the Conversion, including, among other things, the waiver of redemption rights in connection with the Business Combination. Following the Conversion, there were 3,552,768 Class A Ordinary Shares issued and outstanding (including 552,768 Public Shares) and 4,666,667 Class B Ordinary Shares issued and outstanding. The Conversion did not result in any cash proceeds to the Company and did not affect the amount held in the Trust Account.

 

16

 

 

Warrants 

 

As of September 30, 2026 and December 31, 2025, there were 11,500,000 Public Warrants and 6,000,000 Private Placement Warrants outstanding. Public Warrants may only be exercised for a whole number of shares. No fractional Public Warrants will be issued upon separation of the Units and only whole Public Warrants will trade. The Public Warrants will become exercisable 30 days after the completion of a Business Combination. The Company has agreed that as soon as practicable, but in no event later than 20 business days after the closing of the Business Combination, the Company will use its commercially reasonable efforts to file with the SEC a post-effective amendment to the registration statement for the Initial Public Offering or a new registration statement covering the registration under the Securities Act of the Class A Ordinary Shares issuable upon exercise of the Warrants and thereafter the Company will use its commercially reasonable efforts to cause the same to become effective within 60 business days following the initial Business Combination and to maintain a current prospectus relating to the Class A Ordinary Shares issuable upon exercise of the Warrants until the expiration of the Warrants in accordance with the provisions of the Public Warrant agreement.

 

The Company may redeem the Public Warrants:

 

  ● in whole and not in part;

 

  ● at a price of $0.01 per warrant;

 

  ● upon a minimum of 30 days’ prior written notice of redemption to each warrant holder; and

 

  ● if, and only if, the last reported sale price (the “closing price”) of the Ordinary Shares equals or exceeds $18.00 per share (as adjusted) for any 20 trading days within a 30-trading day period commencing once the Warrants become exercisable and ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders.

 

The Company will not redeem the Public Warrants as described above unless a registration statement under the Securities Act covering the Ordinary Shares issuable upon exercise of the Public Warrants is then effective and a current prospectus relating to those Ordinary Shares is available throughout the 30-day redemption period. Any such exercise would not be on a cashless basis and would require the exercising warrant holder to pay the exercise price for each Public Warrant being exercised. The Private Placement Warrants are identical to the Public Warrants sold in the Initial Public Offering, except that the Private Placement Warrants and the Ordinary Shares issuable upon exercise of the Private Placement Warrants will not be transferable, assignable or saleable until 30 days after the completion of the Business Combination, subject to certain limited exceptions. In no event will the Company be required to net cash settle any Warrant. If the Company is unable to complete a Business Combination and the Company liquidates the funds held in the Trust Account, holders of Warrants will not receive any of such funds with respect to their Warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with respect to such Warrants. Accordingly, the Warrants may expire worthless.

 

NOTE 7 – COMMITMENTS AND CONTINGENCIES

 

Registration Rights

 

The holders of Founder Shares, Private Placement Warrants, and securities that may be issued upon conversion of Working Capital Loans, if any, are entitled to registration rights pursuant to a registration rights agreement, dated July 9, 2024, in connection with the Initial Public Offering. These holders are entitled to make up to three demands, excluding short form demands, that the Company registers such securities. In addition, these holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of the Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

 

17

 

 

Underwriting Agreement

 

The Company granted the Underwriters a 45-day option from the date of its Initial Public Offering to purchase up to 3,000,000 Option Units, to cover over-allotments, if any (the “Over-Allotment Option”). On July 11, 2024, simultaneously with the closing of the Initial Public Offering, the underwriters elected to fully exercise the Over-Allotment Option to purchase the additional 3,000,000 Option Units at a price of $10.00 per Option Unit. As a result of the Underwriters’ election to fully exercise their Over-Allotment Option, an aggregate of 1,000,000 Founder Shares is no longer subject to forfeiture.

 

The Underwriters received an underwriting discount of $0.20 per Unit (excluding those Option Units sold as part of the Over-Allotment Option), or $4,000,000 in the aggregate, paid upon the closing of the Initial Public Offering. The Underwriters agreed to the Original Deferred Underwriting Fee equal to $0.45 per unit on Units other than those sold pursuant to the Over-Allotment Option and $0.65 per unit on Option Units sold pursuant to the Over-Allotment Option, or $10,950,000 in the aggregate. Upon completion of the Business Combination, such $10,950,000 was to be paid to the Underwriters from the funds held in the Trust Account. The Original Deferred Underwriting Fee was to become payable to the Underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement, dated July 9, 2024, which the Company entered into with Cantor, as representative of the Underwriters.

 

Fee Reduction Agreement

 

On January 28, 2026, the Company entered into a fee reduction agreement with the Sponsor and Cantor, as representative of the Underwriters (the “Fee Reduction Agreement”). Pursuant to the Fee Reduction Agreement, and subject to the consummation of a Business Combination, Cantor has instead agreed to receive a non-refundable cash fee equal to 1.5% of the aggregate amount delivered from the Trust Account upon the closing of the initial Business Combination (the “Reduced Deferred Fee”). The Reduced Deferred Fee will be payable upon the closing of the initial Business Combination. If the Company (or a successor) fails to pay the Reduced Deferred Fee in full at such time, Cantor may elect to require the Company to pay the full amount of the Original Deferred Underwriting Fee in cash. In addition, if the Company or the Sponsor becomes entitled to receive any break-up, termination or similar fee in connection with a proposed Business Combination that is terminated, abandoned or otherwise not consummated, 50% of the amount of such fee shall be applied toward payment of the Reduced Deferred Fee, subject to certain limitations set forth in the Fee Reduction Agreement. Because the Original Deferred Underwriting Fee was originally charged to Class A Ordinary Shares subject to possible redemption, the $10,950,000 liability was derecognized on January 28, 2026 with a corresponding credit to Class A Ordinary Shares subject to possible redemption. As Class A Ordinary Shares subject to possible redemption are carried at redemption value, the Company immediately remeasured the carrying value to redemption value, which resulted in a credit of $10,950,000 to accumulated deficit, as no additional paid-in capital was available. The waiver had no effect on the condensed statements of operations or on net income per share. See Note 2 for a reconciliation of Class A Ordinary Shares subject to possible redemption. The Reduced Deferred Fee is payable only upon the consummation of a Business Combination and, accordingly, no liability has been recognized for it as of September 30, 2026.

 

Legal Fee Arrangement

 

On September 2, 2026, the Company entered into an engagement letter with its legal counsel with respect to the proposed Business Combination with AIT or an alternative Business Combination, documenting an engagement that began in March 2026. Pursuant to the engagement letter, the Company paid an advance fee deposit of $500,000 on September 3, 2026, which is applied against fees billed for services relating to the Business Combination, including services rendered prior to the date of the engagement letter. Fees in excess of $500,000 (the “Deferred Legal Fee”) and any other amounts outstanding prior to the date of the engagement letter are due upon consummation of the Business Combination, and a premium equal to 20% of the Deferred Legal Fee is payable upon successful consummation of a Business Combination. If a Business Combination is not consummated and the Company dissolves, counsel will not receive any of the Deferred Legal Fee other than out-of-pocket expenses and amounts payable from funds available outside of the Trust Account, if any. As of September 30, 2026, $378,028 of the advance had been applied to fees for services relating to the Business Combination and $121,972 remained, which is included in prepaid expenses in the accompanying condensed balance sheet. As of September 30, 2026, accounts payable and accrued expenses in the accompanying condensed balance sheet also include $186,542 of fees billed by counsel for services rendered prior to the date of the engagement letter (invoices dated November 30, 2025 through June 30, 2026), which, under the engagement letter, are payable upon consummation of the Business Combination. Because the premium is contingent upon the consummation of a Business Combination, no amount has been recognized for the premium as of September 30, 2026.

 

18

 

 

NOTE 8 – FAIR Value Measurements

 

At issuance, the fair value of the Company’s financial assets and liabilities reflects Management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities).

 

The following table presents information about the Company’s assets that are measured at fair value on a recurring basis at September 30, 2026:

 

    September 30,
2026
    Quoted
Prices in
Active
Markets
(Level 1)
    Significant
Other
Observable
Inputs
(Level 2)
    Significant
Unobservable
Inputs
(Level 3)
 
Assets:                        
Cash and marketable securities held in Trust Account   $ 6,168,416     $ 6,168,416     $ —     $ —  

 

The following table presents information about the Company’s assets that are measured at fair value on a recurring basis at December 31, 2025:

 

    December 31,
2025
    Quoted
Prices in
Active
Markets
(Level 1)
    Significant
Other
Observable
Inputs
(Level 2)
    Significant
Unobservable
Inputs
(Level 3)
 
Assets:                        
Cash and marketable securities held in Trust Account   $ 245,118,303     $ 245,118,303     $ —     $ —  

 

The Public Warrants were valued using a Monte Carlo model. The Public Warrants have been classified within shareholders’ deficit and will not require remeasurement after issuance. The following table presents the quantitative information regarding market assumptions used in the valuation of the Public Warrants:

 

    July 11,
2024
 
Calculated share price   $ 9.91  
Weighted-average expected life of Warrants in years     2.97  
Risk-free rate     4.39 %
Pre-Business Combination annual volatility     2.0 %
Post-Business Combination annual volatility     33.0 %
Market pricing adjustment     19.0 %

 

The Founder Shares issued to the directors and director nominees were valued using a Market Approach Methodology. The following table presents the quantitative information regarding market assumptions used in the Founder Shares valuation:

 

    April 18,
2024
 
Discount for probability of failure to complete Initial Public Offering     10.0 %
Market pricing adjustment     87.0 %
Discount for expected forfeiture     15.0 %

 

Transfers to/from Levels 1, 2 and 3 are recognized at the end of the reporting period in which a change in valuation technique or methodology occurs. There were no transfers for the three and nine months ended September 30, 2026 or September 30, 2025.

 

19

 

 

NOTE 9 – SEGMENT INFORMATION

 

FASB ASC Topic 280,”Segment Reporting” establishes standards for companies to report financial statement information about operating segments, products, services, geographic areas, and major customers. Operating segments are defined as components of an enterprise for which separate financial information is available that is regularly evaluated by the Company’s chief operating decision maker (“CODM”), or group, in deciding how to allocate resources and assess performance.

 

The CODM has been identified as the Chief Financial Officer, who reviews the operating results for the Company as a whole to make decisions about allocating resources and assessing financial performance. Accordingly, Management has determined that the Company only has one operating segment. When evaluating the Company’s performance and making key decisions regarding resource allocation the CODM reviews several key metrics, which include the following:

 

    For the
three months
ended
September 30,
2026
    For the
three months
ended
September 30,
2025
    For the
nine months
ended
September 30,
2026
    For the
nine months
ended
September 30,
2025
 
General and administrative expenses   $ 425,843     $ 258,011     $ 1,153,269     $ 681,018  
Interest expense on Promissory Note - Sponsor     43,578       -       75,310       -  
Interest earned on cash and marketable securities held in Trust Account     55,853       2,510,176       3,225,584       7,453,481  

 

The key measures of segment profit or loss reviewed by the CODM are interest earned on cash and marketable securities held in the Trust Account, general and administrative expenses and interest expense on the WCL Promissory Note. The CODM reviews interest earned on cash and marketable securities held in the Trust Account to measure and monitor shareholder value and determine the most effective strategy of investment with the Trust Account funds while maintaining compliance with the investment management trust agreement, dated July 9, 2024, by and between the Company and Continental Stock Transfer & Trust Company, trustee of the Trust Account. General and administrative expenses are reviewed and monitored by the CODM to manage and forecast cash to ensure enough capital is available to complete a Business Combination within the Combination Period. The CODM also reviews general and administrative expenses to manage, maintain and enforce all contractual agreements to ensure costs are aligned with all agreements and budget. The CODM also reviews interest expense on the WCL Promissory Note, which is paid in kind, in managing the Company’s liquidity.

 

NOTE 10 – Subsequent Events

 

The Company evaluated subsequent events and transactions that occurred after the accompanying condensed balance sheet date through the date that the accompanying unaudited condensed financial statements were issued. Based upon this review, other than as set forth below, the Company did not identify any subsequent events that would have required adjustment or disclosure in the accompanying unaudited condensed financial statements.

 

On October 2, 2026, the Company entered into a binding letter of intent with AIT (the “Binding LOI”), which superseded the LOI in its entirety. As described in the Company’s Current Report on Form 8-K filed with the SEC on October 5, 2026, AIT would merge with a newly formed, wholly owned subsidiary of the Company, with AIT surviving, and the Company (following its domestication from the Cayman Islands to the State of Nevada) would issue approximately 50,000,000 shares of common stock to the equity holders of AIT at closing. The combined company would adopt an equity incentive plan for awards of up to 10.0% of its fully diluted capitalization, and John Chiorando, the current Chief Executive Officer of AIT, would serve as Chief Executive Officer and Chairman of the combined company. Certain significant AIT stockholders would be subject to a 12-month lock-up. Consummation of the transaction is subject to, among other things, satisfactory completion of due diligence, execution of definitive documents and approval by the boards of directors and shareholders of each party. The exclusivity period was extended through December 31, 2026. AIT is required to pay the Company a termination fee of $5,000,000 in specified circumstances, including if AIT fails to deliver certain audited and reviewed financial statements by November 15, 2026 or if definitive documents are not executed by December 31, 2026; under the Fee Reduction Agreement, 50% of any such fee received would be applied toward the Reduced Deferred Fee (see Note 7). The Binding LOI was filed as an exhibit to the Company’s Current Report on Form 8-K filed with the SEC on October 5, 2026. The parties are negotiating a definitive merger agreement, which had not been executed as of the date of this Report.

 

On November 13, 2026, the Company and the Sponsor entered into the First Amendment to the WCL Promissory Note, which increases the maximum principal amount of the WCL Promissory Note from $1,500,000 to $2,000,000 and provides that the $38,158 funded by the Sponsor on August 27, 2026 in excess of the second draw does not bear interest, will be applied toward the Company’s next draw and, to the extent not applied, will be repaid at maturity of the WCL Promissory Note. Following the amendment, $500,001 of principal is available under the WCL Promissory Note. The other terms of the WCL Promissory Note are unchanged.

 

20

 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

Cautionary Note Regarding Forward-Looking Statements

 

All statements other than statements of historical fact included in this Report including, without limitation, statements under this Item regarding our financial position, possible Business Combinations and the financing thereof, and related matters and the plans and objectives of Management for future operations, are forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act. When used in this Report, words such as “may,” “should,” “could,” “would,” “anticipate,” “believe,” “estimate,” “expect,” “intend” and similar expressions, as they relate to us or our Management, identify forward-looking statements. We have based these forward-looking statements on our Management’s current expectations and projections about future events, as well as assumptions made by, and information currently available to, our Management. Actual results could differ materially from those contemplated by the forward-looking statements as a result of certain factors detailed in our filings with the SEC. All subsequent written or oral forward-looking statements attributable to us or persons acting on our behalf are qualified in their entirety by this paragraph.

 

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with the unaudited condensed financial statements and the notes thereto included in this Report under “Item 1. Financial Statements”.

 

Overview

 

We are a blank check company incorporated as a Cayman Islands exempted company on January 29, 2024 for the purpose of effecting a Business Combination. Our Sponsor is SIM Sponsor 1 LLC. On October 2, 2026, we entered into the Binding LOI with AIT, as described below under “Recent Developments.” We intend to effectuate our initial Business Combination using cash from the proceeds of the Initial Public Offering and the Private Placement, the proceeds of the sale of our shares in connection with our initial Business Combination (pursuant to any forward purchase agreements or backstop agreements into which we may enter following the consummation of the Initial Public Offering or otherwise), shares issued to the owners of the target, debt issued to bank or other lenders or the owners of the target, other securities issuances, or a combination of the foregoing.

 

The issuance of additional shares in connection with a Business Combination to the owners of the target or other investors:

 

  ● may significantly dilute the equity interest of investors in the Initial Public Offering, which dilution would increase if the anti-dilution provisions in the Class B Ordinary Shares resulted in the issuance of Class A Ordinary Shares on a greater than one-to-one basis upon conversion of the Class B Ordinary Shares;

 

  ● may subordinate the rights of holders of Class A Ordinary Shares if preference shares are issued with rights senior to those afforded our Class A Ordinary Shares;

 

  ● could cause a change in control if a substantial number of our Class A Ordinary Shares are issued, which may affect, among other things, our ability to use our net operating loss carry forwards, if any, and could result in the resignation or removal of our present officers and directors;

 

  ● may have the effect of delaying or preventing a change of control of us by diluting the share ownership or voting rights of a person seeking to obtain control of us; and

 

  ● may adversely affect prevailing market prices for our Class A Ordinary Shares and/or Warrants.

 

21

 

 

Similarly, if we issue debt securities or otherwise incur significant debt to bank or other lenders or the owners of a target, it could result in:

 

  ● default and foreclosure on our assets if our operating revenues after an initial Business Combination are insufficient to repay our debt obligations;

 

  ● acceleration of our obligations to repay the indebtedness even if we make all principal and interest payments when due if we breach certain covenants that require the maintenance of certain financial ratios or reserves without a waiver or renegotiation of that covenant;

 

  ● our immediate payment of all principal and accrued interest, if any, if the debt security is payable on demand;

 

  ● our inability to obtain necessary additional financing if the debt security contains covenants restricting our ability to obtain such financing while the debt security is outstanding;

 

  ● using a substantial portion of our cash flow to pay principal and interest on our debt, which will reduce the funds available for expenses, capital expenditures, acquisitions and other general corporate purposes;

 

  ● limitations on our flexibility in planning for and reacting to changes in our business and in the industry in which we operate;

 

  ● increased vulnerability to adverse changes in general economic, industry and competitive conditions and adverse changes in government regulation; and

 

  ● limitations on our ability to borrow additional amounts for expenses, capital expenditures, acquisitions, debt service requirements, execution of our strategy and other purposes and other disadvantages compared to our competitors who have less debt.

 

Pursuant to the Amended and Restated Articles, if we are unable to complete the initial Business Combination by July 12, 2027 (or such earlier time as determined by our Board), and such Combination Period is not further extended by shareholders, we will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible, but not more than ten business days thereafter, redeem 100% of the outstanding Public Shares at a per share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned thereon (less taxes payable and up to $100,000 of interest income to pay dissolution expenses) and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining shareholders and the Board, liquidate and dissolve. The Warrants will expire on liquidation of the Trust Account and the holders of Warrants will receive no proceeds in connection with the liquidation. The holders of the Founder Shares will not participate in any redemption distribution with respect to their Founder Shares.

 

Recent Developments

 

Entry into Letters of Intent

 

On April 26, 2026, we entered into the LOI with AIT for its Acquisition upon the terms and conditions to be set forth in certain definitive documents and negotiations.

 

Among other segments, AIT operates Q1, a leader in telecommunications that has evolved into a fully integrated platform spanning manufacturing, logistics, distribution, and connected device ecosystems. Building on its deep relationships with Tier 1 and Tier 2 carriers, AIT has scaled a robust third-party logistics and fourth-party logistics and e-commerce infrastructure that supports global distribution across the United States, Europe, and Latin America.

 

22

 

 

On August 13, 2026, the LOI was extended until October 31, 2026.

 

On October 2, 2026, we entered into the Binding LOI with AIT, which superseded the LOI in its entirety. As described in our Current Report on Form 8-K filed with the SEC on October 5, 2026, AIT would merge with a newly formed, wholly owned subsidiary of ours, with AIT surviving, and we (following our domestication from the Cayman Islands to the State of Nevada) would issue approximately 50,000,000 shares of common stock to the equity holders of AIT at closing. The combined company would adopt an equity incentive plan for awards of up to 10.0% of its fully diluted capitalization, and John Chiorando, the current Chief Executive Officer of AIT, would serve as Chief Executive Officer and Chairman of the combined company. Certain significant AIT stockholders would be subject to a 12-month lock-up. Consummation of the transaction is subject to, among other things, satisfactory completion of due diligence, execution of definitive documents and approval by the boards of directors and shareholders of each party. The exclusivity period was extended through December 31, 2026. AIT is required to pay us a termination fee of $5,000,000 in specified circumstances, including if AIT fails to deliver certain audited and reviewed financial statements by November 15, 2026 or if definitive documents are not executed by December 31, 2026; under the Fee Reduction Agreement, 50% of any such fee received would be applied toward the Reduced Deferred Fee. The Binding LOI was filed as an exhibit to our Current Report on Form 8-K filed with the SEC on October 5, 2026. The parties are negotiating a definitive merger agreement, which had not been executed as of the date of this Report.

 

Extension of Our Combination Period

 

On May 7, 2026, we held the 2026 EGM to approve, among other things, the Extension Amendment Proposal. In connection with the vote to approve the Extension Amendment Proposal, Public Shareholders holding 22,447,232 Public Shares (after giving effect to withdrawals of redemptions) exercised their right to redeem such Public Shares for cash at a redemption price of approximately $10.79 per Public Share, for an aggregate redemption amount of $242,175,471 in the 2026 Redemptions.

 

We may seek to further extend the Combination Period consistent with applicable laws, regulations and stock exchange rules by amending our Amended and Restated Articles. Any such amendment would require the approval of our shareholders, and our Public Shareholders will be provided the opportunity to redeem all or a portion of their Public Shares in connection with the vote on such approval. Such redemptions will decrease the amount held in our Trust Account and our capitalization, and may affect our ability to maintain our listing on Nasdaq. In addition, the Nasdaq Rules currently require SPACs (such as us) to complete their initial Business Combination in accordance with the Nasdaq 36-Month Requirement, which for us is July 9, 2027, three days prior to the end of the Combination Period. If we do not meet the Nasdaq 36-Month Requirement, our securities will likely be subject to a suspension of trading and delisting from Nasdaq.

 

Founder Share Conversion

 

On May 11, 2026, 3,000,000 Class B Ordinary Shares held by our Sponsor were converted into 3,000,000 Class A Ordinary Shares on a one-for-one basis (the “Conversion”). The Class A Ordinary Shares issued in connection with the Conversion are subject to the same restrictions as applied to the Class B Ordinary Shares prior to the Conversion, including, among other things, the waiver of redemption rights in connection with the Business Combination. Following the Conversion, there were 3,552,768 Class A Ordinary Shares issued and outstanding (including 552,768 Public Shares) and 4,666,667 Class B Ordinary Shares issued and outstanding.

 

Results of Operations

 

We have neither engaged in any operations nor generated any revenues to date. Our only activities since January 29, 2024 (inception) through September 30, 2026 have been (i) organizational activities and (ii) activities relating to (x) the Initial Public Offering, and (y) identifying and evaluating prospective acquisition candidates and activities in connection with the initial Business Combination. We will not generate any operating revenues until after completion of our initial Business Combination. We have generated non-operating income in the form of interest income on investments held in the Trust Account after the Initial Public Offering. We expect to incur increased expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance, among other things), as well as for due diligence expenses.

 

23

 

 

For the three months ended September 30, 2026, we had a net loss of $413,568, which consists of $425,843 of general and administrative costs and $43,578 of interest expense on the WCL Promissory Note, offset by $55,853 of interest income earned on the Trust Account. For the three months ended September 30, 2025, we had net income of $2,252,165, which includes $2,510,176 of interest earned on the Trust Account, offset by $258,011 of general and administrative costs.

 

For the nine months ended September 30, 2026, we had net income of $1,997,005, which includes $3,225,584 of interest income earned on the Trust Account, offset by $1,153,269 of general and administrative costs and $75,310 of interest expense on the WCL Promissory Note. For the nine months ended September 30, 2025, we had net income of $6,772,463, which includes $7,453,481 of interest earned on the Trust Account, offset by $681,018 of general and administrative costs. The decrease in interest income for the three and nine months ended September 30, 2026 compared to the prior year periods is primarily due to the reduction in the balance of the Trust Account following the 2026 Redemptions. The increase in general and administrative costs compared to the prior year periods is primarily attributable to legal and professional fees incurred in connection with the proposed Business Combination with AIT. Interest expense on the WCL Promissory Note, which was issued in March 2026, consists of paid-in-kind interest and amortization of original issue discount and is not paid in cash.

 

Liquidity, Capital Resources and Going Concern

 

Until the consummation of the Initial Public Offering, our only source of liquidity was an initial purchase of Class B Ordinary Shares by the Sponsor and loans from the Sponsor pursuant to the IPO Promissory Note.

 

On July 11, 2024, we consummated the Initial Public Offering of 23,000,000 Units, which includes the full exercise by the Underwriters of their Over-Allotment Option in the amount of 3,000,000 Option Units, at $10.00 per unit, generating gross proceeds of $230,000,000. The net proceeds from the sale of the Units in the Initial Public Offering and the sale of the Private Placement Warrants in the Private Placement for an aggregate purchase price of $6,000,000, after deducting offering expenses of $477,616 and underwriting commissions of $4,000,000 (excluding the Original Deferred Underwriting Fee of $10,950,000), was $231,522,384. $230,000,000 was initially deposited in the Trust Account.

 

The proceeds held in the Trust Account are invested in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act which invest only in direct U.S. government treasury obligations. The holding of these assets in this form is intended to be temporary and for the sole purpose of facilitating the intended Business Combination. To mitigate the risk that we might be deemed to be an investment company for purposes of the Investment Company Act, which risk increases the longer that we hold investments in the Trust Account, we may, at any time, (based on our Management Team’s ongoing assessment of all factors related to our potential status under the Investment Company Act) instruct the trustee to liquidate the investments held in the Trust Account and instead to hold the funds in the Trust Account in cash or in an interest bearing demand deposit account at a bank.

 

We intend to use substantially all of the funds held in the Trust Account, including any amounts representing interest earned on the Trust Account (less the Reduced Deferred Fee and taxes payable), to complete our initial Business Combination. We may withdraw interest to pay our taxes, if any. To the extent that our equity or debt is used, in whole or in part, as consideration to complete our initial Business Combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue our growth strategies.

 

In connection with the vote to approve the Extension Amendment Proposal at the 2026 EGM, Public Shareholders holding 22,447,232 Public Shares exercised their right to redeem such Public Shares for cash at a redemption price of approximately $10.79 per Public Share, for an aggregate redemption amount of $242,175,471, which was paid from the Trust Account in May 2026. As of September 30, 2026, there was $6,168,416 in cash and marketable securities held in the Trust Account.

 

As of September 30, 2026, we had cash held outside of the Trust Account of $280,224. We will use these funds primarily to identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, plants or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of prospective target businesses, and structure, negotiate and complete a Business Combination. For the nine months ended September 30, 2026, net cash used in operating activities was $1,248,360; net cash provided by investing activities was $242,175,471, reflecting the withdrawal from the Trust Account to pay the 2026 Redemptions; and net cash used in financing activities was $240,712,314, reflecting the 2026 Redemptions, offset by $1,424,999 of proceeds from the WCL Promissory Note, net of OID, and $38,158 funded by the Sponsor in excess of the second draw.

 

24

 

 

In order to fund working capital deficiencies or finance transaction costs in connection with an intended initial Business Combination, our Sponsor or an affiliate of our Sponsor or certain of our officers and directors may, but are not obligated to, loan us Working Capital Loans as may be required. If we complete our initial Business Combination, we intend to repay such Working Capital Loans. In the event that our initial Business Combination does not close, we may use amounts held outside the Trust Account to repay such Working Capital Loans, but no proceeds from our Trust Account will be used for such repayment. The WCL Promissory Note is not convertible. Up to $1,500,000 of any other Working Capital Loans may be convertible into warrants of the post-Business Combination entity at a price of $1.00 per warrant at the option of the lender. Such warrants would be identical to the Private Placement Warrants. Prior to the completion of our initial Business Combination, we do not expect to seek loans from parties other than our Sponsor or an affiliate of our Sponsor as we do not believe third parties will be willing to loan such funds and provide a waiver against any and all rights to seek access to funds in our Trust Account. On March 18, 2026, the Company issued the WCL Promissory Note in the aggregate principal amount of up to $1,500,000 to the Sponsor. On August 27, 2026, the Sponsor funded $763,158 under the WCL Promissory Note, and as of September 30, 2026, $1,499,999 of the $1,500,000 principal amount had been drawn. As of September 30, 2026 and December 31, 2025, the Company borrowed a total of $1,499,999 and $0, respectively, under Working Capital Loans pursuant to the WCL Promissory Note. On November 13, 2026, the WCL Promissory Note was amended to increase its maximum principal amount to $2,000,000, leaving $500,001 of principal available.

 

We have until July 12, 2027 to consummate a Business Combination. It is uncertain that we will be able to consummate a Business Combination by this time. If a Business Combination is not consummated by this date, there will be a mandatory liquidation and subsequent dissolution of our Company. In connection with our assessment of going concern considerations in accordance with FASB ASC Topic 205-40, “Presentation of Financial Statements—Going Concern,” as of September 30, 2026, Management has determined that the mandatory liquidation and subsequent dissolution raises substantial doubt about our ability to continue as a going concern. The unaudited condensed financial statements included in this Report under “Item 1. Financial Statements” do not include any adjustments that may be necessary if we are unable to continue as a going concern. No adjustments have been made to the carrying amounts of assets or liabilities should we be required to liquidate after July 12, 2027. In addition, our cash balance does not exceed our current budgeted operating requirements, and Management has concluded that this indicates we will not have sufficient liquidity to meet its obligations as they become due within one year after the date the unaudited condensed financial statements included in this Report under “Item 1. Financial Statements” are issued. Management plans to address these conditions by consummating the proposed Business Combination with AIT and, if needed, by drawing the $500,001 of principal available under the WCL Promissory Note, as amended on November 13, 2026, and by obtaining additional Working Capital Loans from our Sponsor or its affiliates, which are under no obligation to provide them. These plans are not within our control and are not considered probable of alleviating the substantial doubt.

 

Contractual Obligations

 

We do not have any long-term debt, capital lease obligations, operating lease obligations or long-term liabilities, other than as follows:

 

Promissory Note with Sponsor

 

On March 18, 2026, we issued the WCL Promissory Note. Pursuant to the WCL Promissory Note, the interest rate is 12.0% per annum, based on the actual number of days elapsed over a 360-day year. The first draw, of $736,841 of principal, was funded on March 25, 2026 at a 5.0% original issue discount (“OID”) of $36,842, for cash proceeds of $699,999; the second draw, of $763,158 of principal, was funded on August 27, 2026 at an OID of $38,158, for cash proceeds of $725,000; the Sponsor wired $763,158, and the $38,158 excess is due to the Sponsor. The OID is amortized to interest expense on a straight-line basis over the period to July 12, 2027, the end of the Combination Period, which does not differ materially from the interest method. The effective interest rates, including the OID, are approximately 17.3% per annum on the first draw and 19.6% per annum on the second draw. Interest is paid in kind quarterly by adding it to the principal balance. The WCL Promissory Note is due and payable upon the earlier to occur of: (1) our initial Business Combination, or (2) our liquidation. On July 31, 2026, we delivered a request to the Sponsor to fund a second draw under the WCL Promissory Note, which was funded on August 27, 2026. As a result, $1,499,999 of the $1,500,000 principal amount had been drawn as of September 30, 2026. As of September 30, 2026, the WCL Promissory Note had a face amount of $1,499,999 plus $56,355 of paid-in-kind interest ($1,556,354 in total) and a net carrying value of $1,500,309, reflecting $56,045 of unamortized original issue discount. For the three and nine months ended September 30, 2026, we recognized $43,578 and $75,310, respectively, of interest expense on the WCL Promissory Note, consisting of paid-in-kind interest and amortization of the OID. On November 13, 2026, the WCL Promissory Note was amended to increase its maximum principal amount to $2,000,000, leaving $500,001 of principal available.

 

25

 

 

Administrative Services Agreements

 

We paid $10,000 per month to our Sponsor or an affiliate thereof for office space, utilities, and secretarial and administrative support pursuant to an administrative services agreement, dated July 9, 2024, by and between us and SIM Management LP, an affiliate of the Sponsor. We began incurring these fees on July 9, 2024 and were to continue to incur these fees monthly until the earlier of the completion of the Business Combination and our liquidation. On January 28, 2026, such administrative services agreement was terminated, and any accrued obligations under the Administrative Services Agreement were waived.

 

On March 18, 2026, we entered into an administrative services agreement with Dominari, pursuant to which Dominari provides office space, utilities and secretarial and administrative support to us in exchange for $20,000 per month. Mr. Hayes, our Chairman, is the Chief Executive Officer of Dominari and Mr. Devall, our Chief Executive Officer, is the Chief Operating Officer of Dominari. Commencing in May 2026, such $20,000 monthly fee has been paid $10,000 per month to Dominari and $10,000 per month to Torian Investment Advisers LLC, an affiliated entity of Mr. Kutcher, our Chief Financial Officer. As of September 30, 2026, we have paid $140,000 pursuant to this agreement. For the three and nine months ended September 30, 2026, we incurred $60,000 and $140,000, respectively, in fees under this agreement, which are included in general and administrative expenses. As of September 30, 2026, no amounts were accrued or prepaid under this agreement.

 

Fee Reduction Agreement

 

Pursuant to the Underwriting Agreement, Cantor was previously entitled to receive deferred underwriting commissions in the aggregate amount of $10,950,000 (the “Original Deferred Underwriting Fee”) upon the consummation of our initial Business Combination. On January 28, 2026, we entered into a fee reduction agreement with our Sponsor and Cantor, as representative of the Underwriters (the “Fee Reduction Agreement”). Pursuant to the Fee Reduction Agreement, and subject to the consummation of a Business Combination, Cantor has instead agreed to receive a non-refundable cash fee equal to 1.5% of the aggregate amount delivered from the Trust Account upon the closing of our initial Business Combination (the “Reduced Deferred Fee”). The Reduced Deferred Fee will be payable upon the closing of our initial Business Combination. If we (or our successor) fail to pay the Reduced Deferred Fee in full at such time, Cantor may elect to require us to pay the full amount of the Original Deferred Underwriting Fee in cash. In addition, if we or the Sponsor becomes entitled to receive any break-up, termination or similar fee in connection with a proposed Business Combination that is terminated, abandoned or otherwise not consummated, 50% of the amount of such fee shall be applied toward payment of the Reduced Deferred Fee, subject to certain limitations set forth in the Fee Reduction Agreement.

 

Legal Fee Arrangement

 

On September 2, 2026, we entered into an engagement letter with our legal counsel with respect to the proposed Business Combination with AIT or an alternative Business Combination, documenting an engagement that began in March 2026. Pursuant to the engagement letter, we paid an advance fee deposit of $500,000 on September 3, 2026, which is applied against fees billed for services relating to the Business Combination, including services rendered prior to the date of the engagement letter. Fees in excess of $500,000 (the “Deferred Legal Fee”) and any other amounts outstanding prior to the date of the engagement letter are due upon consummation of the Business Combination, and a premium equal to 20% of the Deferred Legal Fee is payable upon successful consummation of a Business Combination. If a Business Combination is not consummated and we dissolve, counsel will not receive any of the Deferred Legal Fee other than out-of-pocket expenses and amounts payable from funds available outside of the Trust Account, if any. As of September 30, 2026, $378,028 of the advance had been applied to fees for services relating to the Business Combination and $121,972 remained, which is included in prepaid expenses in our condensed balance sheet. As of September 30, 2026, accounts payable and accrued expenses in our condensed balance sheet also include $186,542 of fees billed by counsel for services rendered prior to the date of the engagement letter (invoices dated November 30, 2025 through June 30, 2026), which, under the engagement letter, are payable upon consummation of the Business Combination. Because the premium is contingent upon the consummation of a Business Combination, no amount has been recognized for the premium as of September 30, 2026.

 

26

 

 

Critical Accounting Estimates

 

The preparation of the unaudited condensed financial statements and notes thereto included in this Report under “Item 1. Financial Statements” in conformity with GAAP requires Management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and income and expenses during the periods reported. Making estimates requires Management to exercise significant judgement. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed financial statements included in this Report under “Item 1. Financial Statements”, which Management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, actual results could materially differ from those estimates. As of September 30, 2026 and December 31, 2025, we did not have any critical accounting estimates to be disclosed.

 

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

 

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information otherwise required under this Item.

 

Item 4. Controls and Procedures.

 

Evaluation of Disclosure Controls and Procedures

 

Disclosure controls and procedures are designed with the objective of ensuring that information required to be disclosed in our reports filed under the Exchange Act, such as the Report, is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures are also designed with the objective of ensuring that such information is accumulated and communicated to our Management, including our Certifying Officers, as appropriate, to allow timely decisions regarding required disclosure. Under the supervision and with the participation of our Management, including our Certifying Officers, we carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act. Based on the foregoing, our Certifying Officers concluded that our disclosure controls and procedures were effective as of September 30, 2026.

 

We do not expect that our disclosure controls and procedures will prevent all errors and all instances of fraud. Disclosure controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the disclosure controls and procedures are met. Further, the design of disclosure controls and procedures must reflect the fact that there are resource constraints, and the benefits must be considered relative to their costs. Because of the inherent limitations in all disclosure controls and procedures, no evaluation of disclosure controls and procedures can provide absolute assurance that we have detected all our control deficiencies and instances of fraud, if any. The design of disclosure controls and procedures also is based partly on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.

 

Changes in Internal Control over Financial Reporting

 

There have been no changes to our internal control over financial reporting during the quarterly period ended September 30, 2026 that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

27

 

 

PART II – OTHER INFORMATION

 

Item 1. Legal Proceedings.

 

To the knowledge of our Management Team, there is no material litigation currently pending or contemplated against us, any of our officers or directors in their capacity as such or against any of our property.

 

Item 1A. Risk Factors.

 

As a smaller reporting company under Rule 12b-2 of the Exchange Act, we are not required to include risk factors in the Report. However, for detailed descriptions of the risks relating to our Company, see the section titled “Risk Factors” contained in our (i) IPO Registration Statement, (ii) Quarterly Report on Form 10-Q for the period ended March 31, 2024, (iii) 2024 Annual Report, (iv) Quarterly Reports on Form 10-Q for the periods ended March 31, 2025 and June 30, 2025, (v) 2025 Annual Report, (vi) Definitive Proxy Statement on Schedule 14A, as filed with the SEC on March 31, 2026, and (vii) 2026 First Quarter Form 10-Q and 2026 Second Quarter Form 10-Q. As of the date of this Report, there have been no material changes with respect to those risk factors. Any of these previously disclosed risk factors could result in a significant or material adverse effect on our results of operations or financial condition. Additional risks not presently known to us or that we currently deem immaterial may also affect our ability to consummate an initial Business Combination. We may disclose changes to such risk factors or disclose additional risk factors from time to time in our future filings with the SEC.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

 

Unregistered Sales of Equity Securities

 

None.

 

Use of Proceeds

 

On July 11, 2024, we consummated the Initial Public Offering of 23,000,000 Units, including 3,000,000 Option Units issued pursuant to the full exercise of the Over-Allotment Option, at $10.00 per Unit, generating gross proceeds of $230,000,000. Cantor acted as representative of the Underwriters. The securities sold in the Initial Public Offering were registered under the Securities Act on the IPO Registration Statement (File No. 333-280274), which was declared effective by the SEC on July 9, 2024. Simultaneously with the closing of the Initial Public Offering, we consummated the Private Placement of 6,000,000 Private Placement Warrants to the Sponsor and Cantor at $1.00 per Private Placement Warrant, generating gross proceeds of $6,000,000. Of the gross proceeds of the Initial Public Offering and the Private Placement, $230,000,000 was placed in the Trust Account. We paid $4,000,000 in underwriting discounts and commissions and $477,616 of other offering costs in connection with the Initial Public Offering; the Original Deferred Underwriting Fee of $10,950,000 is no longer payable under the Fee Reduction Agreement. In connection with the 2026 Redemptions, $242,175,471 was withdrawn from the Trust Account in May 2026 and paid to holders of 22,447,232 Public Shares. As of September 30, 2026, $6,168,416 remained in the Trust Account. Other than the repayment of amounts outstanding under the IPO Promissory Note to the Sponsor at the closing of the Initial Public Offering, none of the net proceeds of the Initial Public Offering or the Private Placement were paid, directly or indirectly, to any of our directors or officers, to any person owning 10% or more of any class of our equity securities or to any of our affiliates. Other than as described above, there has been no material change in the planned use of proceeds from the Initial Public Offering and the Private Placement as described in the IPO Registration Statement.

 

28

 

 

Purchases of Equity Securities by the Issuer and Affiliated Purchasers

 

There were no purchases of our equity securities by us or an affiliate during the quarterly period covered by this Report.

 

The following table contains monthly information about the repurchases of our equity securities for the three months ended September 30, 2026:

 

Period   (a)
Total
number of
shares
(or units)
purchased
    (b)
Average
price
paid per
share
(or unit)
    (c)
Total
number of
shares
(or units)
purchased
as part of
publicly
announced
plans or
programs
    (d)
Maximum
number (or
approximate
dollar
value) of
shares (or
units) that
may yet be
purchased
under the
plans or
programs
 
July 1 – July 31, 2026   —    —    —    — 
                     
August 1 – August 31, 2026   —    —    —    — 
                     
September 1 – September 30, 2026   —    —    —    — 

 

Item 3. Defaults Upon Senior Securities.

 

None.

 

Item 4. Mine Safety Disclosures.

 

Not applicable.

 

Item 5. Other Information.

 

Director Nominations

 

There have been no material changes to the procedures by which our security holders may recommend nominees to our Board since we reported such procedures in the 2025 Annual Report.

 

Trading Arrangements

 

During the quarterly period ended September 30, 2026, none of our directors or officers (as defined in Rule 16a-1(f) promulgated under the Exchange Act) adopted or terminated any “Rule 10b5-1 trading arrangement” or any “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K.

 

Additional Information

 

On November 13, 2026, the Company and the Sponsor entered into the First Amendment to the WCL Promissory Note, which increases the maximum principal amount of the WCL Promissory Note from $1,500,000 to $2,000,000 and provides that the $38,158 funded by the Sponsor on August 27, 2026 in excess of the second draw does not bear interest, will be applied toward the Company’s next draw and, to the extent not applied, will be repaid at maturity of the WCL Promissory Note. Following the amendment, $500,001 of principal is available under the WCL Promissory Note. The other terms of the WCL Promissory Note are unchanged. A copy of the amendment is filed as Exhibit 10.1 to this Report.

 

29

 

 

Item 6. Exhibits.

 

The following exhibits are filed as part of, or incorporated by reference into, this Report.

 

No.   Description of Exhibit
10.1   First Amendment to Master Promissory Note, dated November 13, 2026, between the Company and SIM Sponsor 1 LLC.*
31.1   Certification of the Principal Executive Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*
31.2   Certification of the Principal Financial Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*
32.1   Certification of the Principal Executive Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.**
32.2   Certification of the Principal Financial Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.**
101.INS   Inline XBRL Instance Document.*
101.SCH   Inline XBRL Taxonomy Extension Schema Document.*
101.CAL   Inline XBRL Taxonomy Extension Calculation Linkbase Document.*
101.DEF   Inline XBRL Taxonomy Extension Definition Linkbase Document.*
101.LAB   Inline XBRL Taxonomy Extension Label Linkbase Document.*
101.PRE   Inline XBRL Taxonomy Extension Presentation Linkbase Document.*
104   Cover Page Interactive Data File (Embedded as Inline XBRL document and contained in Exhibit 101).*

 

*Filed herewith.

 

**Furnished herewith.

 

30

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

Date: November 13, 2026 SIM ACQUISITION CORP. I
     
  By: /s/ Christopher Devall
  Name:  Christopher Devall
  Title: Chief Executive Officer
    (Principal Executive Officer)

 

Date: November 13, 2026    
     
  By: /s/ David Kutcher
  Name:  David Kutcher
  Title: Chief Financial Officer
    (Principal Financial Officer)

 

31

 

Keep reading